<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-143074" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cancer-Associated Retinopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Dheerendra</given-names>
          </name>
          <aff>ASG Eye Hospital, Bhopal</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dheerendra Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-143074.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Cancer-associated retinopathy (CAR) poses a rare yet critical challenge, often heralding an undiagnosed or recurrent malignancy and causing vision impairment or blindness. This CME activity explores the etiology of CAR as a paraneoplastic autoimmune retinopathy, characterizing it under the broader spectrum of autoimmune retinopathies. Essential investigative methods include visual fields, fundus autofluorescence, fundus fluorescein angiography, spectral-domain optical coherence tomography, electrophysiological tests, and antibody screenings. Historically,&#x000a0;the discovery of CAR in tandem with systemic cancers accentuates its clinical significance and prompts vigilance in diagnosis. Emphasizing interprofessional collaboration, this activity sheds light on evaluation nuances and contemporary management strategies involving systemic steroids, intravenous immunoglobulin, and monoclonal antibodies for optimal CAR care.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the etiology of cancer-associated retinopathy.</p></list-item><list-item><p>Screen for and evaluate&#x000a0;the findings required for the&#x000a0;diagnosis of cancer-associated retinopathy</p></list-item><list-item><p>Compare the different options for the management of cancer-associated retinopathy</p></list-item><list-item><p>Communicate&#x000a0;the importance of patient education and interprofessional team strategies to improve&#x000a0;outcomes for cancer-associated retinopathy</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=143074&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=143074">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-143074.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Acute or subacute loss of visual acuity caused by circulating antibodies formed against the retinal proteins in the presence of systemic cancer is called cancer-associated retinopathy or carcinoma-associated retinopathy (CAR).<xref ref-type="bibr" rid="article-143074.r1">[1]</xref><xref ref-type="bibr" rid="article-143074.r2">[2]</xref><xref ref-type="bibr" rid="article-143074.r3">[3]</xref>&#x000a0;It is described under the broad spectrum of autoimmune retinopathy (AIR) diseases.<xref ref-type="bibr" rid="article-143074.r4">[4]</xref>&#x000a0;Autoimmune retinopathy can be paraneoplastic (pAIR) and nonparaneoplastic (npAIR).<xref ref-type="bibr" rid="article-143074.r5">[5]</xref>&#x000a0;</p>
        <p>Sawyer&#x000a0;et al first described visual loss along with retinal degeneration in patients suffering from lung carcinoma in 1976.<xref ref-type="bibr" rid="article-143074.r6">[6]</xref>&#x000a0;The term paraneoplastic retinopathy (PR) was coined by Klingele&#x000a0;et al to describe autoimmune retinopathy&#x000a0;associated with a distant neoplasm.<xref ref-type="bibr" rid="article-143074.r7">[7]</xref>&#x000a0;They described PR as "a nonmetastatic remote effect of carcinoma and is characterized by rapid visual deterioration accompanied by narrow arterioles seen on ophthalmoscopic examination and an extinguished electroretinogram." In AIR, autoantibodies against retinal proteins are found in the serum of patients without a known malignancy, whereas, in PR, retinal antibodies are seen in the presence of an underlying malignancy.<xref ref-type="bibr" rid="article-143074.r8">[8]</xref>&#x000a0;</p>
        <p>CAR is a rare type of retinal paraneoplastic retinopathy.&#x000a0;Paraneoplastic syndrome is defined as "rare clinical syndromes due to the systemic effects of tumors; they are unrelated to tumor size, invasiveness or metastases."<xref ref-type="bibr" rid="article-143074.r9">[9]</xref>&#x000a0;CAR is&#x000a0;characterized by sudden and progressive vision loss.<xref ref-type="bibr" rid="article-143074.r10">[10]</xref>&#x000a0;Other entities included in the&#x000a0;pAIR visual syndromes are melanoma-associated retinopathy (MAR), paraneoplastic optic neuropathy (PON), and bilateral diffuse uveal melanocytic proliferation (BDUMP).&#x000a0;</p>
        <p>Often, the loss of visual acuity from CAR can occur even before diagnosing cancer.<xref ref-type="bibr" rid="article-143074.r11">[11]</xref>&#x000a0;It has been reported that the diagnosis of CAR (confirmed by the presence of antiretinal antibodies in the sera)&#x000a0;precedes the diagnosis of cancer in up to 50% of patients.<xref ref-type="bibr" rid="article-143074.r12">[12]</xref>&#x000a0;Management options for&#x000a0;CAR include systemic steroids, intravenous immunoglobulin, and various monoclonal antibodies.</p>
      </sec>
      <sec id="article-143074.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Small-cell lung carcinoma (SCLC) is the most important condition associated with&#x000a0;npAIR syndrome.<xref ref-type="bibr" rid="article-143074.r13">[13]</xref>&#x000a0;Associations of CAR&#x000a0;include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Non-SCLC&#x000a0;<xref ref-type="bibr" rid="article-143074.r1">[1]</xref></p>
          </list-item>
          <list-item>
            <p>Breast cancer</p>
          </list-item>
          <list-item>
            <p>Endometrial cancer&#x000a0;<xref ref-type="bibr" rid="article-143074.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Invasive thymoma&#x000a0;<xref ref-type="bibr" rid="article-143074.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Lymphoma&#x000a0;<xref ref-type="bibr" rid="article-143074.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Uterine cervical cancer&#x000a0;<xref ref-type="bibr" rid="article-143074.r16">[16]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Endometroid sarcoma&#x000a0;<xref ref-type="bibr" rid="article-143074.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Myeloma</p>
          </list-item>
          <list-item>
            <p>Basal cell carcinoma&#x000a0;<xref ref-type="bibr" rid="article-143074.r17">[17]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Colon cancer</p>
          </list-item>
          <list-item>
            <p>Kidney cancer&#x000a0;<xref ref-type="bibr" rid="article-143074.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>Leukemia&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Mixed M&#x000fc;llerian tumor</p>
          </list-item>
          <list-item>
            <p>Prostate cancer</p>
          </list-item>
          <list-item>
            <p>Melanoma</p>
          </list-item>
          <list-item>
            <p>Squamous cell carcinoma</p>
          </list-item>
          <list-item>
            <p>Pancreatic cancer</p>
          </list-item>
          <list-item>
            <p>Laryngeal carcinoma&#x000a0;<xref ref-type="bibr" rid="article-143074.r19">[19]</xref></p>
          </list-item>
          <list-item>
            <p>Urinary bladder carcinoma&#x000a0;<xref ref-type="bibr" rid="article-143074.r19">[19]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-143074.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>AIR&#x000a0;accounted for less than 1% of all the cases seen at a tertiary eye center.<xref ref-type="bibr" rid="article-143074.r20">[20]</xref>&#x000a0;The&#x000a0;pAIR syndrome can be seen&#x000a0;in 1 out of 10,000 cancer patients.<xref ref-type="bibr" rid="article-143074.r21">[21]</xref>&#x000a0;Braithwaite et al showed that&#x000a0;pAIR&#x000a0;syndrome eventually develops in approximately 10% to 15% of all cancer patients.<xref ref-type="bibr" rid="article-143074.r22">[22]</xref>&#x000a0;</p>
        <p>CAR is more common in females compared&#x000a0;with males.&#x000a0;Misiuk-Hojlo et al noted that the sera of 6&#x000a0;out of 295 breast cancer patients had&#x000a0;immunoreactivity to retinal antigens, although only 2 cases showed ocular features of CAR.&#x000a0;The mean age of onset of CAR ranges from 55 to 65 years.<xref ref-type="bibr" rid="article-143074.r23">[23]</xref><xref ref-type="bibr" rid="article-143074.r24">[24]</xref>&#x000a0;</p>
        <p>In a case series of 209 patients, Adamus showed that the mean age of CAR was between 40&#x000a0;and 85 years.&#x000a0;Adamus also reported that CAR was mainly associated with malignancy of the breast (31%), followed by lung (16%) and hematological malignancies (15%). SCLC accounts for approximately 29,000 diagnosed cases in the United States annually.<xref ref-type="bibr" rid="article-143074.r25">[25]</xref>&#x000a0;</p>
        <p>The time interval between the onset of retinopathy and the cancer diagnosis can vary from weeks to months (lymphoma and lung cancer) to even years (breast and prostate cancer).</p>
      </sec>
      <sec id="article-143074.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The autoimmune theory was&#x000a0;postulated&#x000a0;by Keltner et al in 1983.<xref ref-type="bibr" rid="article-143074.r11">[11]</xref>&#x000a0;According to the theory, antibodies against retinal photoreceptors were present in the serum of lymphoma patients who developed acute loss of vision and retinal degeneration. The pathological changes seen in CAR result from an interaction between the retinal antigen expression in the cancerous tissues and their systemic immune response. These antigens trigger an autoimmune response within the host to form antibodies that cross-react with the retinal antigen, ultimately causing cell death/apoptosis with retinal degeneration.&#x000a0;</p>
        <p>Thirkill and colleagues, in 1987, first observed the appearance of autoantibodies against the 23 kDa retinal protein in patients with SCLC and&#x000a0;CAR.<xref ref-type="bibr" rid="article-143074.r1">[1]</xref>&#x000a0;The 23 kDa protein implicated as the CAR-antigen was noted to be a "photoreceptor cell-specific protein" or "recoverin-like protein."<xref ref-type="bibr" rid="article-143074.r26">[26]</xref></p>
        <p>Recoverin is regarded as the most commonly involved antigen seen in CAR patients.<xref ref-type="bibr" rid="article-143074.r27">[27]</xref>&#x000a0;It&#x000a0;is a calcium-dependent activator of guanylate cyclase<xref ref-type="bibr" rid="article-143074.r28">[28]</xref>&#x000a0;responsible for light and dark adaptation of the photoreceptors.<xref ref-type="bibr" rid="article-143074.r29">[29]</xref>&#x000a0;The conformational changes induced by activation of the calcium-binding domains present in recoverin protein&#x000a0;play a crucial role in the binding of the antirecoverin antibodies.<xref ref-type="bibr" rid="article-143074.r30">[30]</xref><xref ref-type="bibr" rid="article-143074.r31">[31]</xref><xref ref-type="bibr" rid="article-143074.r32">[32]</xref></p>
        <p>In cancer, the level of vascular endothelial growth factor (VEGF) increases, which causes retinal pericyte loss.<xref ref-type="bibr" rid="article-143074.r33">[33]</xref> This leads to increased permeability and vascular attenuation with subsequent blood&#x02013;retina barrier breakdown.<xref ref-type="bibr" rid="article-143074.r34">[34]</xref><xref ref-type="bibr" rid="article-143074.r35">[35]</xref>&#x000a0;Antibodies then penetrate the membranes of the living photoreceptors by the process of endocytosis and react with recoverin.<xref ref-type="bibr" rid="article-143074.r35">[35]</xref>&#x000a0;Injection of recoverin in Lewis rats resulted in high antibody titer and cell-mediated immunity against recoverin, ultimately leading to features of uveoretinitis, including perivasculitis, vitreous cells, retinal lesions, and loss of retinal photoreceptors.<xref ref-type="bibr" rid="article-143074.r36">[36]</xref>&#x000a0;</p>
        <p>Ohguro&#x000a0;et al&#x000a0;demonstrated that recoverin dysfunction leads to increased phosphorylation of rhodopsin and opening of cyclic guanosine monophosphate (cGMP)-gated channels, causing a rise in the intracellular calcium.<xref ref-type="bibr" rid="article-143074.r37">[37]</xref>&#x000a0;This further leads to the activation of Bcl-2 proteins and caspases 3 and 9, initiating the apoptosis cascade with the breakdown of DNA and cell degeneration.</p>
        <p>The gene for recoverin is present on chromosome 17p13.1.<xref ref-type="bibr" rid="article-143074.r38">[38]</xref>&#x000a0;In patients with lung cancer, increased recoverin protein expression caused by hypomethylation of DNA within the promoter region is seen.<xref ref-type="bibr" rid="article-143074.r39">[39]</xref>&#x000a0;Recoverin protein within the cancer tissues&#x000a0;with antirecoverin antibodies can be demonstrated in cancer patients with no evidence of CAR.<xref ref-type="bibr" rid="article-143074.r40">[40]</xref>&#x000a0;Recoverin antibodies may have an antitumor effect and&#x000a0;may denote a longer survival rate with lesser recurrence in patients with SCLC.<xref ref-type="bibr" rid="article-143074.r41">[41]</xref>&#x000a0;</p>
        <p>Recoverin&#x000a0;may aid in cancer treatment by causing cancer cells to become more sensitive to the chemotherapy&#x000a0;or by becoming the target for cancer treatment.&#x000a0;Bazhin AV et al analyzed serial samples of tumor tissues and sera from 143 patients with lung cancer and showed that on account of a high occurrence of aberrant expression of recoverin in lung tumors, targeting recoverin as a paraneoplastic antigen may play a role in immunotherapy of lung cancer.<xref ref-type="bibr" rid="article-143074.r42">[42]</xref>&#x000a0;The autoimmune reactions that occur against the cancerous cells expressing recoverin can also contribute to the systemic control of malignancy.<xref ref-type="bibr" rid="article-143074.r43">[43]</xref></p>
        <p>Adamus et al showed that antirecoverin antibodies can be detected in only 10% of patients with visual symptoms&#x000a0;and identified the presence of autoantibodies against &#x003b1;-enolase (46 kDa) and transducin-&#x003b1; (40 kDa) in the serum of patients with CAR and nonneoplastic retinopathy.<xref ref-type="bibr" rid="article-143074.r44">[44]</xref><xref ref-type="bibr" rid="article-143074.r45">[45]</xref>&#x000a0;Enolase is a glycolytic enzyme found in rods, cones, ganglion cells, and&#x000a0;M&#x000fc;ller cells.&#x000a0;Three different isoforms of enolase have been described, but the anti&#x02013;&#x003b1;-enolase antibodies have mostly been reported in CAR.<xref ref-type="bibr" rid="article-143074.r46">[46]</xref></p>
        <p>Vision loss in enolase-associated retinopathy is less severe as compared to recoverin-associated retinopathy.&#x000a0;Recoverin-associated retinopathy has an acute onset with&#x000a0;faster progression.&#x000a0;Anti-enolase antibodies have been associated with breast, prostate, and hematologic cancers.<xref ref-type="bibr" rid="article-143074.r47">[47]</xref> Antibodies against&#x000a0;&#x003b1;-enolase can also be found in about 11% of healthy individuals.<xref ref-type="bibr" rid="article-143074.r48">[48]</xref>&#x000a0;Other conditions showing autoantibodies against&#x000a0;&#x003b1;-enolase include Beh&#x000e7;et disease, mixed cryoglobulinemia,&#x000a0;inflammatory bowel disease,&#x000a0;primary sclerosing cholangitis, systemic lupus erythematosus (SLE), multiple sclerosis, and systemic sclerosis.<xref ref-type="bibr" rid="article-143074.r49">[49]</xref><xref ref-type="bibr" rid="article-143074.r50">[50]</xref>&#x000a0;</p>
        <p>Ohguro et al suggested that humoral autoimmunity against recoverin and heat shock cognate protein 70 (65 kDa) may play a role in the pathogenesis of CAR.<xref ref-type="bibr" rid="article-143074.r51">[51]</xref>&#x000a0;Other antigens&#x000a0;associated with&#x000a0;CAR include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anticarbonic anhydrase II (30 kDa)&#x000a0;<xref ref-type="bibr" rid="article-143074.r52">[52]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Anti&#x02013;glyceraldehyde 3-phosphate dehydrogenase (GAPDH)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Interphotoreceptor retinoid-binding protein (145 kDa)&#x000a0;<xref ref-type="bibr" rid="article-143074.r53">[53]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Neurofilament proteins&#x000a0;<xref ref-type="bibr" rid="article-143074.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p>Tubby-like protein 1 [TULP1]&#x000a0;<xref ref-type="bibr" rid="article-143074.r54">[54]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Arrestin</p>
          </list-item>
          <list-item>
            <p>Heat shock cognate (HSC) protein 70&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Guanylyl cyclase&#x02013;activating proteins (GCAP) 1 and 2&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Photoreceptor-specific nuclear receptor 9PNR)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Rab6A GTPase (Rab6A) and other unidentified antibodies formed against the retinal proteins</p>
          </list-item>
        </list>
        <p>T-cells are also involved in the pathogenesis of CAR. CAR enhancement occurs by blockade of the negative T-cell signaling via the cytotoxic T-lymphocyte antigen-4 (CTLA-4).<xref ref-type="bibr" rid="article-143074.r55">[55]</xref>&#x000a0;The CTLA-4 receptor is expressed by the regulatory T cells, which block the&#x000a0; interleukin-2 (IL-2) expression and inhibit T-cell activation. This leads to a downregulation of the immune response.&#x000a0;T-cell activation caused by the antagonism of the CTLA-4 is instrumental in various autoimmune diseases and in causing immune-related cancer regression.<xref ref-type="bibr" rid="article-143074.r56">[56]</xref><xref ref-type="bibr" rid="article-143074.r57">[57]</xref>&#x000a0;Therefore, for CAR to develop, exposure to recoverin or other retinal antigens, along with immune modulation in the form of blockade of CTLA-4 signaling, is required.</p>
      </sec>
      <sec id="article-143074.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathological examination reveals patchy photoreceptor loss.<xref ref-type="bibr" rid="article-143074.r35">[35]</xref>&#x000a0;Immunohistochemical analysis shows that serum from patients with CAR selectively stains the outer retina (inner and outer segment of most photoreceptors, outer nuclear layer, and outer plexiform layer).&#x000a0;Though both the inner and outer segments of rods appeared to stain, many of the cone inner segments did not stain in a study.<xref ref-type="bibr" rid="article-143074.r58">[58]</xref>&#x000a0;The occurrence of cross-reactivity with the optic nerve tissue has also been noted.<xref ref-type="bibr" rid="article-143074.r59">[59]</xref>&#x000a0;</p>
        <p>The retinal pigment epithelium and choroid are usually not involved&#x000a0;in CAR, contrary to&#x000a0;retinitis pigmentosa.&#x000a0;Immunohistochemical staining of the retina varies depending upon the specific type of antibody involved in the pathogenesis.&#x000a0;Recoverin-mediated CAR shows predominant photoreceptor staining.&#x000a0;Sawyer et al showed photoreceptor degeneration of rods and cones and scattered melanophages in the outer retina and sparing of the ganglion cells in the inner retinal layer.<xref ref-type="bibr" rid="article-143074.r6">[6]</xref></p>
      </sec>
      <sec id="article-143074.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>CAR leads to progressive and rapid visual loss caused by rod and cone dysfunction with retinal degeneration. It is characterized by acquired, acute, or subacute sudden, bilateral,&#x000a0; progressive, painless visual deterioration, which can sometimes have a chronic presentation.&#x000a0;Even though CAR is usually bilaterally symmetrical, it can be asymmetric and sequential or rarely even have a unilateral presentation.<xref ref-type="bibr" rid="article-143074.r60">[60]</xref>&#x000a0;</p>
        <p>Early cases of CAR may mimic various other conditions and may be difficult to diagnose. Nonspecific complaints are not uncommon and include glare, photosensitivity, reduced vision, especially in scotopic conditions, floaters, photopsia, apparent graying or darkening of the surrounding environment, transient visual obscurations, and bizarre visual sensations. Clinical features of cone dysfunction are decreased visual acuity, abnormal color vision,&#x000a0;metamorphopsia, central scotoma, and abnormal cone-mediated electroretinogram (ERG).<xref ref-type="bibr" rid="article-143074.r61">[61]</xref><xref ref-type="bibr" rid="article-143074.r62">[62]</xref>&#x000a0;</p>
        <p>Rod dysfunction&#x000a0;leads to prolonged dark adaptation, nyctalopia, constricted visual fields, mid-peripheral or ring scotomas, and abnormal rod-mediated ERG.&#x000a0;Loss of vision in patients with CAR can occur over weeks to months.&#x000a0;Patients with recoverin antibodies in their serum have a diffuse involvement of both rods and cones and suffer from profound visual impairment compared to patients with&#x000a0;anti&#x02013;&#x003b1;-enolase antibodies.&#x000a0;Patients with anti&#x02013;&#x003b1;-enolase antibodies are also less likely to develop nyctalopia due to more limited central cone involvement.<xref ref-type="bibr" rid="article-143074.r63">[63]</xref>&#x000a0;</p>
        <p>Visual symptoms in CAR may manifest even months or years before the diagnosis of the neoplasm and occur due to the remote effect of the neoplasm.&#x000a0;The interval&#x000a0;may be as long as 11 years.<xref ref-type="bibr" rid="article-143074.r64">[64]</xref>&#x000a0;Jacobson and colleagues suggested that pAIR should be suspected in patients with the triad of "photosensitivity, ring scotomatous visual field loss, and attenuated retinal arteriole caliber."<xref ref-type="bibr" rid="article-143074.r65">[65]</xref>&#x000a0;</p>
        <p>Recent-onset acquired nyctalopia in an elderly patient with no family history of retinitis pigmentosa or no evidence of vitamin A deficiency are other clinical clues for diagnosing CAR. A slit-lamp examination may reveal the presence of low-grade inflammation in the anterior chamber or cellular debris in the anterior vitreous.&#x000a0;The fundus may appear&#x000a0;normal, but some patients may have retinal pigment abnormalities in the form of bony spicules or atrophy of the retinal pigment epithelium,&#x000a0;vascular attenuation, and optic disc pallor.&#x000a0;Other fundus findings include vascular sheathing, macular edema, periphlebitis, chorioretinal atrophy, and vitritis.&#x000a0;Vitritis may be seen in up to 20% of patients.&#x000a0;Cancer patients also develop cataracts at an early age.<xref ref-type="bibr" rid="article-143074.r66">[66]</xref>&#x000a0;</p>
        <p>Malignancy is associated with the overproduction of&#x000a0;reactive oxygen species (ROS).<xref ref-type="bibr" rid="article-143074.r67">[67]</xref>&#x000a0;This oxidative stress may damage the lens proteins, resulting in lens opacification and early-onset cataracts.<xref ref-type="bibr" rid="article-143074.r68">[68]</xref></p>
      </sec>
      <sec id="article-143074.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Various modalities are used to confirm the diagnosis of CAR.</p>
        <p>
<bold>Visual Fields&#x000a0;</bold>
</p>
        <p>Visual field testing usually shows constriction of fields.&#x000a0;Other visual field defects include central, cecocentral, or equatorial scotomas and enlargement of the blind spot.<xref ref-type="bibr" rid="article-143074.r22">[22]</xref><xref ref-type="bibr" rid="article-143074.r69">[69]</xref>&#x000a0;</p>
        <p>
<bold>Fundus Autofluorescence&#x000a0;</bold>
</p>
        <p>Fundus autofluorescence (FAF)&#x000a0;is an important noninvasive tool used to analyze patients with CAR; it uses a scanning laser ophthalmoscope and is based on the evaluation of lipofuscin.<xref ref-type="bibr" rid="article-143074.r70">[70]</xref>&#x000a0;Lipofuscin is a fluorophore derived from&#x000a0;photoreceptor outer segments.<xref ref-type="bibr" rid="article-143074.r71">[71]</xref>&#x000a0;Photoreceptor death and retinal pigment epithelium (RPE) atrophy cause hypoautofluorescence (decreased autofluorescence), whereas increased RPE function causes hyperautofluorescence (increased autofluorescence).<xref ref-type="bibr" rid="article-143074.r72">[72]</xref><xref ref-type="bibr" rid="article-143074.r73">[73]</xref>&#x000a0;</p>
        <p>CAR is characterized by a hyperautofluorescent parafoveal ring with normal autofluorescence within the ring and hypoautofluorescence outside the ring, primarily centered in the macular and peripapillary region.&#x000a0;Hyperautofluorescent rings can also be seen in multiple disorders, including retinitis pigmentosa,&#x000a0;X-linked retinoschisis,&#x000a0;Leber congenital amaurosis, and&#x000a0;cone dystrophy.<xref ref-type="bibr" rid="article-143074.r74">[74]</xref><xref ref-type="bibr" rid="article-143074.r75">[75]</xref><xref ref-type="bibr" rid="article-143074.r76">[76]</xref>&#x000a0;In Retinitis Pigmentosa, a parafoveal ring of increased autofluorescence (Robson-Holder ring) can be seen in up to 59% of patients.<xref ref-type="bibr" rid="article-143074.r77">[77]</xref>&#x000a0;</p>
        <p>The Robson-Holder ring represents an area of lipofuscin accumulation around a preserved subfoveal RPE.<xref ref-type="bibr" rid="article-143074.r78">[78]</xref>&#x000a0;FAF can detect even minute structural changes in patients with CAR, which are difficult to identify on an ophthalmoscope. Hence, it should be incorporated as a part of the standard imaging protocol for such patients.</p>
        <p>
<bold>Fundus Fluorescein Angiography&#x000a0;</bold>
</p>
        <p>Fundus Fluorescein Angiography (FFA) is usually normal. Infrequent findings include optic nerve head staining,&#x000a0;perivascular leakage&#x000a0;in vasculitis, and petaloid leak at the macula in cystoid macular edema.&#x000a0;Peripheral subtle window defects corresponding to retinal degeneration may also be seen.<xref ref-type="bibr" rid="article-143074.r64">[64]</xref><xref ref-type="bibr" rid="article-143074.r79">[79]</xref>&#x000a0;</p>
        <p>
<bold>Spectral-Domain Optical Coherence Tomography</bold>
</p>
        <p>Spectral-Domain Optical Coherence Tomography (SD-OCT) provides an objective measure of the amount of retinal damage that has occurred and is also helpful in diagnosing CAR.&#x000a0;It may detect the presence of CAR in the early stages.<xref ref-type="bibr" rid="article-143074.r80">[80]</xref><xref ref-type="bibr" rid="article-143074.r81">[81]</xref>&#x000a0;See <bold>Image.</bold>&#x000a0;Cancer-Associated Retinopathy.</p>
        <p>SD-OCT shows loss of the outer retinal complex, including disruption of the ellipsoid zone (EZ) and thinning of the photoreceptor layer.&#x000a0;Abazari&#x000a0;et al demonstrated the presence of outer retinal abnormalities and decreased central macular thickness on SD-OCT in CAR patients.<xref ref-type="bibr" rid="article-143074.r81">[81]</xref>&#x000a0;Similarly, Sepah et al showed<italic toggle="yes">&#x000a0;</italic>a<italic toggle="yes">&#x000a0;</italic>statistically significant loss of the photoreceptor layer in CAR patients.<xref ref-type="bibr" rid="article-143074.r82">[82]</xref>&#x000a0;</p>
        <p>OCT findings depend upon both the severity and the duration of the disease.&#x000a0;Diagnostic delay accounts for deterioration in the visual acuity and imminent&#x000a0;reduction in the subfoveal EZ.&#x000a0;Cystic spaces or the presence of cystoid macular edema (CME) is also a frequent finding.&#x000a0;Larson et al, in a study among 17 patients with autoimmune retinopathy, showed CME to be the most prevalent finding seen in 24% of the patients.&#x000a0;Patients&#x000a0;with CME at initial presentation have a greater rate of EZ loss than those without CME.<xref ref-type="bibr" rid="article-143074.r83">[83]</xref>&#x000a0;</p>
        <p>The condition is also more aggressive in patients with CME, which manifests in reduced a and b waves in the electroretinogram.<xref ref-type="bibr" rid="article-143074.r84">[84]</xref>&#x000a0;Vitreomacular traction induced by an epiretinal membrane has also been reported in patients with CAR.<xref ref-type="bibr" rid="article-143074.r85">[85]</xref>&#x000a0;Occasionally,&#x000a0;mild schisis-like changes can also be seen.&#x000a0;Intact EZ and external limiting membrane on OCT in patients before treatment may denote good visual recovery.<xref ref-type="bibr" rid="article-143074.r86">[86]</xref></p>
        <p><bold>Electrophysiological Tests</bold>&#x000a0;</p>
        <p>These measure&#x000a0;the electrical activity generated by the eye, the optic pathways, and the visual cortex.&#x000a0;The full-field electroretinogram (ffERG) provides information about activity in the rod and cone systems and other neural elements.<xref ref-type="bibr" rid="article-143074.r87">[87]</xref>&#x000a0;ERG may be a more sensitive tool than OCT, and ffERG is abnormal in the early stage of the disease.&#x000a0;However, some cases may have involvement of the central cones, which is only evident in&#x000a0;multifocal ERG (mfERG).&#x000a0;</p>
        <p>The mfERG&#x000a0;indicates the topographical location of the&#x000a0;response within the retina.&#x000a0;Measurement of the integrity of the retinal pigment epithelium is given by the electrooculogram&#x000a0;(EOG).&#x000a0;The a-wave of ffERG indicates the response of the photoreceptors.&#x000a0;The b-wave can be photopic and scotopic.&#x000a0;The photopic, cone-driven b-wave reflects the activity of the on and off bipolar cells, whereas the scotopic, rod-driven b-wave reflects the activity of the on-type bipolar cells.&#x000a0;</p>
        <p>Photoreceptor damage affects both the a and b-waves,&#x000a0;whereas conditions affecting the bipolar cells result in an absent b-wave with a wave showing negative deflection.&#x000a0;Oscillatory potentials (OPs) represent the activity of a complex feedback circuit&#x000a0;that includes amacrine cells, bipolar cells, and interplexiform cells.<xref ref-type="bibr" rid="article-143074.r88">[88]</xref><bold>&#x000a0;</bold>Responses such as delayed b-waves, the extinguishing of a- and b-waves involving the rods and cones,&#x000a0;reduced b-waves, and an electronegative ERG may be seen in patients with CAR.<xref ref-type="bibr" rid="article-143074.r89">[89]</xref><xref ref-type="bibr" rid="article-143074.r90">[90]</xref>&#x000a0;</p>
        <p>Electronegative ERG is more typical of melanoma-associated retinopathy. ffERG is almost always abnormal, showing absent or attenuation flash responses in photopic and scotopic conditions.&#x000a0;When cones are mainly affected, ffERG might be normal, but the multifocal ERG is abnormal.<xref ref-type="bibr" rid="article-143074.r91">[91]</xref>&#x000a0;</p>
        <p>In a case series of 10 patients by Thirkill et al, loss of rod and cone amplitudes with normal or prolonged implicit times were seen in patients with&#x000a0;antirecoverin antibody&#x02013;associated CAR.<xref ref-type="bibr" rid="article-143074.r1">[1]</xref>&#x000a0;Weleber et al, in a case series of 12 patients, showed that&#x000a0;anti&#x02013;enolase-associated retinopathy is associated with more central or global cone dysfunction than rod dysfunction.<xref ref-type="bibr" rid="article-143074.r63">[63]</xref>&#x000a0;In a case series of 39 patients, Adamus et al showed abnormal electroretinogram findings in patients with anti&#x02013;rod transducin-&#x003b1; associated with npAIR and CAR.<xref ref-type="bibr" rid="article-143074.r44">[44]</xref>&#x000a0;The patients associated with&#x000a0;anti&#x02013;rod transducin-&#x003b1; were usually females (female-to-male ratio, 2:1), had abnormal rod function, and typically, there was no evidence of cancer.<xref ref-type="bibr" rid="article-143074.r44">[44]</xref></p>
        <p><bold>Antibody Testing</bold>&#x000a0;</p>
        <p>The presence of antiretinal antibodies in cancer patients was first shown by Kornguth&#x000a0;et al<xref ref-type="bibr" rid="article-143074.r92">[92]</xref>.&#x000a0;Testing can be done using immunohistochemistry, western blotting, enzyme-linked immunosorbent assay (ELISA, or multiplex assay systems.&#x000a0;Adamus&#x000a0;et al first showed that clinical manifestations in CAR vary based on the triggering antigens and the circulating antibodies.&#x000a0;Diffuse rod and cone involvement is seen in CAR patients with antirecoverin antibodies.<xref ref-type="bibr" rid="article-143074.r63">[63]</xref>&#x000a0;</p>
        <p>Patients with&#x000a0;anti&#x02013;&#x003b1;-enolase antibodies have limited involvement of the central cones.&#x000a0;CAR associated&#x000a0;with transducin-&#x003b1; antibodies has more rod degeneration.&#x000a0;Serum antibody levels may be found to be elevated even after completion of treatment of the primary neoplasm, and it may also be associated with the progression of CAR.&#x000a0;However, fluctuating autoantibody levels in the serum do not indicate cancer recurrence or progression.&#x000a0;</p>
        <p>The role of serial serum antiretinal antibody levels for longitudinal monitoring requires further research, and technical difficulty and cost limit its regular use.&#x000a0;It is important to note that antiretinal antibodies can be found even in the normal population and patients with nonparaneoplastic autoimmune retinopathy.&#x000a0;Ko&#x000a0;et al showed<italic toggle="yes">&#x000a0;</italic>the<italic toggle="yes">&#x000a0;</italic>presence of antiretinal antibodies in 42% of normal individuals.<xref ref-type="bibr" rid="article-143074.r93">[93]</xref>&#x000a0;Hence, positive antiretinal antibodies alone are not diagnostic of CAR.&#x000a0;Antiretinal antibodies can also be found in the sera of patients with systemic autoimmune diseases like&#x000a0;Beh&#x000e7;et disease, SLE, and age-related macular degeneration.<xref ref-type="bibr" rid="article-143074.r94">[94]</xref>&#x000a0;Khanna et al, in a review of 20 eyes of 15 patients with autoimmune retinopathy, showed a higher percentage of anti-enolase antibodies in the serum and staining of the photoreceptor layer in patients that developed CME.<xref ref-type="bibr" rid="article-143074.r83">[83]</xref></p>
        <p>As CAR can precede the underlying cancer diagnosis by several months,&#x000a0;running a systemic survey facilitated by the primary care physician is essential. This includes a thorough medical history with physical examination, complete blood investigations, MRI of the brain, CT of the chest, abdomen, and pelvis, whole-body PET, and other appropriate tests such as mammogram, colonoscopy, prostate and genitourinary system evaluation, and others. This extensive methodology is pivotal in determining the treatment protocol and prognosis of the patient.<xref ref-type="bibr" rid="article-143074.r35">[35]</xref></p>
        <p>There are no set diagnostic criteria for CAR. The diagnosis is made by combining the patient's clinical symptoms, exam findings, diagnosis of systematic cancer, and positive antibodies against retinal proteins. A patient's visual symptoms may precede cancer diagnosis, making the diagnosis of CAR difficult initially.</p>
      </sec>
      <sec id="article-143074.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Early initiation of treatment for CAR is critical for the preservation of vision. CAR associated with untreated antirecoverin antibodies may lead to severe vision loss and even no perception of light.<xref ref-type="bibr" rid="article-143074.r63">[63]</xref>&#x000a0;The treatment must be targeted toward the ocular condition because the removal of underlying cancer does not affect the course of CAR.&#x000a0;However, regression of the primary neoplasm brings about a significant decline in the circulating autoantibodies.<xref ref-type="bibr" rid="article-143074.r95">[95]</xref>&#x000a0;No standardized approach or protocol has been laid for treating paraneoplastic retinopathy.&#x000a0;The management of CAR is often difficult, and visual loss may progress despite therapy.</p>
        <p>Systemic steroids can be used for treatment, but they have variable outcomes.&#x000a0;The use of corticosteroids has been seen to be more efficient in the short-term management of CAR associated with recoverin-mediated auto-antibodies.&#x000a0;Keltner&#x000a0;et al first used serum auto-antibody&#x02013;guided prednisone to control intraocular disease in a cancer patient.<xref ref-type="bibr" rid="article-143074.r2">[2]</xref>&#x000a0;The dose of initial oral prednisone may be as high as 1&#x000a0;to 2 mg/kg/day.<bold>&#x000a0;</bold>Other treatment options include intravitreal&#x000a0;triamcinolone&#x000a0;and subtenon triamcinolone (40-60 mg).<xref ref-type="bibr" rid="article-143074.r96">[96]</xref><xref ref-type="bibr" rid="article-143074.r97">[97]</xref>&#x000a0;However, periocular or intraocular steroids can cause a rise in intraocular pressure, which has to be controlled with topical medications.<xref ref-type="bibr" rid="article-143074.r98">[98]</xref>&#x000a0;</p>
        <p>Intravenous methylprednisolone (500 mg/day for&#x000a0;3 days), when integrated with resection of the primary neoplasm, can lay down notable short-term improvement, as reported by Dot et al.<xref ref-type="bibr" rid="article-143074.r14">[14]</xref>&#x000a0;The use of intravenous methylprednisolone is associated with more favorable outcomes as compared to oral prednisone and hence can be used to initiate the treatment.<xref ref-type="bibr" rid="article-143074.r99">[99]</xref>&#x000a0;Plasmapheresis coupled with prednisone may also show beneficial effects in patients with CAR.<xref ref-type="bibr" rid="article-143074.r95">[95]</xref></p>
        <p>Multiple steroid-sparing immunomodulatory agents have been used to treat CAR, but no single therapy has shown consistency or long-term efficacy.&#x000a0;Systemic azathioprine (100 mg/day),&#x000a0;cyclosporine (100 mg/day), and mycophenolate mofetil (2&#x000a0;g/day)&#x000a0;have been used in the management of CAR.&#x000a0;Parallel and synchronous use of multiple agents can be done to hold up the visual decline. Ferreyra&#x000a0;et al showed that supplementation of immunosuppressive agents (eg, azathioprine [100 mg/day]&#x000a0;and cyclosporine [100 mg/day]) causes improvement in visual acuity and visual fields with stabilization in ERG in patients with CAR associated with recoverin autoantibodies.<xref ref-type="bibr" rid="article-143074.r98">[98]</xref>&#x000a0;</p>
        <p>Guy&#x000a0;et al showed stabilization in patients with CAR using intravenous immunoglobulins (IVIG).&#x000a0;IVIG (400 mg/kg/d for&#x000a0;5 days) can improve visual acuity and field.<xref ref-type="bibr" rid="article-143074.r100">[100]</xref>&#x000a0;However, CAR associated with&#x000a0;anti&#x02013;&#x003b1;-enolase antibodies is challenging to manage even with IVIG. The use of IVIG and plasmapheresis in the CAR treatment is appropriate if given before the onset of irreversible neuronal degeneration.</p>
        <p>Newer treatment modalities include the use of newer monoclonal antibodies such as alemtuzumab (anti-CD52, pan-lymphocyte)&#x000a0;dosed at&#x000a0;30 mg intravenously&#x000a0;3 times a week for&#x000a0;4 months)&#x000a0;and rituximab (anti-CD20, B-cell)&#x000a0;in patients who have failed prednisone and IVIG.<xref ref-type="bibr" rid="article-143074.r35">[35]</xref><xref ref-type="bibr" rid="article-143074.r101">[101]</xref></p>
        <p>Rituximab&#x000a0;dosed at 1000 mg twice a week of 2 doses or 375 mg once a week for&#x000a0;4 weeks, when combined with immunosuppressive agents (eg, prednisone, azathioprine, infliximab, cyclosporine, and mycophenolate), gave beneficial effects in the form of stable or improved visual outcomes in 77% of eyes in a retrospective case series of 16 patients (30 eyes) with autoimmune retinopathy (including&#x000a0;1 melanoma-associated retinopathy,&#x000a0;6 CAR, and&#x000a0;9 npAIR patients).<xref ref-type="bibr" rid="article-143074.r102">[102]</xref></p>
        <p>Ohguro&#x000a0;et al showed improvement in ERG and a delay in the progression of the disease by&#x000a0;pharmacological reduction of intracellular calcium (nilvadipine) in experimental animals.&#x000a0;The antirecoverin antibodies get localized in the photoreceptor cells to block the recoverin function and regulate rhodopsin,&#x000a0;resulting in the enhancement of phosphorylation of rhodopsin and induction of apoptotic cell death.<xref ref-type="bibr" rid="article-143074.r103">[103]</xref>&#x000a0;</p>
        <p>Retinal dysfunction may be prevented by decreasing the phosphorylation of light-dependent rhodopsin or by antagonism of the intracellular calcium levels.&#x000a0;AdamIn an experimental CAR model,&#x000a0;a study&#x000a0;demonstrated that nifedipine might protect from apoptosis.<xref ref-type="bibr" rid="article-143074.r104">[104]</xref>&#x000a0;However, there might be progressive loss in visual acuity despite calcium channel blocker monotherapy in humans.&#x000a0;Hence, the effectiveness of using calcium channel blockers or tinted glasses to reduce the ambient light in curbing the pathogenesis of CAR in human beings needs further exploration.</p>
        <p>Antioxidants and vitamins like lutein, vitamin C, vitamin E, and beta carotene (in nonsmokers) may help stabilize retinal degeneration and the disease course. However, their exact role may need further evaluation.&#x000a0;Future treatment for CAR is directed towards inhibiting vascular<italic toggle="yes">&#x000a0;</italic>endothelial growth factor (VEGF) receptor 1 to prevent the penetration of antibodies. Calcium modulation&#x000a0;and ciliary neurotrophic factor (CNTF) gene transfer may cause a delay in apoptosis.<xref ref-type="bibr" rid="article-143074.r105">[105]</xref>&#x000a0;Monoclonal antibodies targeted towards B-cell inhibition can also be used as a safer mode of treatment for patients with CAR.</p>
      </sec>
      <sec id="article-143074.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>It is important to differentiate CAR from a number of other conditions.</p>
        <p>
<bold>Retinitis Pigmentosa</bold>
</p>
        <p>Retinitis pigmentosa is associated with family history&#x000a0;and is inherited by various modes (autosomal dominant, X-linked, autosomal recessive, or sporadic).<xref ref-type="bibr" rid="article-143074.r106">[106]</xref><xref ref-type="bibr" rid="article-143074.r107">[107]</xref>&#x000a0;Antiretinal antibodies can be found circulating in around 10% to 37% of patients with retinitis pigmentosa.<xref ref-type="bibr" rid="article-143074.r108">[108]</xref>&#x000a0;Features like retinal degeneration may also be seen secondary to retinitis pigmentosa; however, in CAR, minimal inflammation occurs, and usually, there is sparing of the retinal pigment epithelium and choroid.<bold>&#x000a0;</bold>The reason for the similarity is sharing a common target in the form of the S-antigen and interphotoreceptor retinoid-binding protein.<xref ref-type="bibr" rid="article-143074.r109">[109]</xref>&#x000a0;</p>
        <p>In retinitis pigmentosa, there is a predominant rod photoreceptor dysfunction with a later cone photoreceptor and retinal pigment epithelium dysfunction.&#x000a0;The disease manifests during adolescence with the chief complaint of night blindness and mid-peripheral visual loss (due to rod cell damage) and the development of tunnel vision at later stages.<xref ref-type="bibr" rid="article-143074.r110">[110]</xref>&#x000a0;Typical features of retinitis pigmentosa include arteriolar attenuation, changes in the retinal pigment epithelium (RPE), and a waxy disc pallor.<xref ref-type="bibr" rid="article-143074.r111">[111]</xref>&#x000a0;Other features such as&#x000a0;RPE depigmentation and atrophy, cystic macular lesions, posterior subcapsular cataracts, vitreous cells, and refractive errors (myopia and astigmatism) may also be seen.<xref ref-type="bibr" rid="article-143074.r112">[112]</xref>&#x000a0;CAR is differentiated by acquired nyctalopia, which usually starts at or after the 6th decade;&#x000a0; usually, there is no family history.</p>
        <p>
<bold>npAIR</bold>
</p>
        <p>npAIR was first&#x000a0;described&#x000a0;in 1997.&#x000a0;The phenotype and electrophysiological tests seen in npAIR are similar to those in CAR.&#x000a0;It is usually associated with an autoimmune family history, and hence, it needs more intense immunosuppressive therapy.&#x000a0;npAIR has a slower progression rate than CAR,&#x000a0;the visual changes are more subtle, and the age of presentation is usually younger.&#x000a0;npAIR can be associated with photopsia, dyschromatopsia, and nyctalopia.&#x000a0;The presence of macular edema and chorioretinal atrophy also points towards npAIR.<xref ref-type="bibr" rid="article-143074.r113">[113]</xref>&#x000a0;</p>
        <p>The antirecoverin antibodies are usually found in the sera of patients with suspected npAIR.&#x000a0;Other antiretinal antibodies associated with npAIR include anticarbonic anhydrase II, anti&#x02013;&#x003b1;-enolase,&#x000a0;antirecoverin, and anti&#x02013;rod transducin-&#x003b1; antibodies.&#x000a0;Adamus et al, after analyzing 193 patients with retinopathy with or without neoplasia, reported that antibodies against recoverin are found in the serum of patients with cancer, whereas&#x000a0;&#x003b1;-enolase antibodies were found in all the other patients.<xref ref-type="bibr" rid="article-143074.r23">[23]</xref>&#x000a0;Systemic conditions associated with npAIR include hypothyroidism, rheumatoid arthritis, multiple sclerosis, autoimmune hepatitis, Hashimoto thyroiditis, Myasthenia gravis, Graves disease, and bullous pemphigoid.</p>
        <p>
<bold>Melanoma-associated Retinopathy&#x000a0;</bold>
</p>
        <p>CAR is most commonly associated with SCLC, whereas MAR is commonly associated with cutaneous malignant melanoma.&#x000a0;CAR usually precedes the diagnosis of neoplasm, whereas MAR usually presents after the diagnosis of melanoma.&#x000a0;MAR typically has a normal fundus but can also present with diffuse RPE changes, white spots, granular macular appearance, optic disc pallor, retinal vascular attenuation, vitelliform material, and&#x000a0;multiple serous retinal detachments.<xref ref-type="bibr" rid="article-143074.r114">[114]</xref>&#x000a0;Vitreous cells may be present and may denote the severity of the autoimmune response.<xref ref-type="bibr" rid="article-143074.r115">[115]</xref></p>
        <p>MAR&#x000a0;stems from&#x000a0;a similar origin as the neuroectoderm of the melanocytes and the retinal cells.<xref ref-type="bibr" rid="article-143074.r115">[115]</xref>&#x000a0;Age at presentation varies from 30&#x000a0;to 78 years, and males are predominantly affected.<xref ref-type="bibr" rid="article-143074.r115">[115]</xref>&#x000a0;Additionally, a family history of autoimmune diseases may be present.</p>
        <p>The typical triad of MAR consists of visual symptoms including night blindness, positive visual phenomena (flickering, pulsating, or shimmering lights that may get worse on exposure to bright light), visual field defects, reduction in b-wave amplitude in ERG, and presence of serum antibody reacting to retinal bipolar cells. The diagnosis of melanoma may precede MAR by 2 months to 19 years, though the interval is usually shorter in metastatic melanoma.</p>
        <p>Usually, both eyes are affected within 2 months, though unilateral cases have also been reported.<xref ref-type="bibr" rid="article-143074.r116">[116]</xref>&#x000a0;A characteristic feature is the preservation of central visual acuity, with most cases having at least 20/60 vision.<xref ref-type="bibr" rid="article-143074.r115">[115]</xref>&#x000a0;Color vision is usually preserved, though subtle discrimination of color may be affected. Reported visual field defects include generalized depression, central or paracentral defects, arcuate scotoma, or constriction of peripheral visual fields.</p>
        <p>Electroretinogram in MAR reveals reduced b-wave and preserved dark-adapted a-wave (electronegative ERG) showing bipolar cell dysfunction.&#x000a0;Circulating autoantibodies against&#x000a0;transient receptor potential cation channel, subfamily M, member 1 (TRPM1), and&#x000a0;bestrophin-1&#x000a0;can be found in patients with MAR. Other antibodies associated with MAR include&#x000a0;anti-aldolase A and C, anti&#x02013;&#x003b1;-enolase, anti-interphotoreceptor retinoid-binding protein, antirecoverin, antirhodopsin, antimitofilin, antititin, and&#x000a0;antitransducin antibodies.</p>
        <p>Therapy for MAR includes cytoreduction and immunotherapy. Cytoreduction aims to reduce tumor burden and stimulus for antibody production. Methods of cytoreduction&#x000a0;include surgery, chemotherapy, and radiation. Immunotherapy aims to reduce circulating autoantibody levels. Options for immunotherapy include steroids, intravenous immunoglobulin, plasmapheresis, and various immunosuppressive therapies.<xref ref-type="bibr" rid="article-143074.r115">[115]</xref></p>
        <p><bold>Acute Zonal Outer Occult Retinopathy and Other White Dot Syndromes</bold>&#x000a0;</p>
        <p>Although acute zonal outer occult retinopathy (AZOOR) can present with symptoms, electroretinogram findings, and visual fields showing an enlarged blind spot similar to CAR, AZOOR is typically a bilateral but asymmetric entity. Hypoautofluorescence is observed in the majority of eyes with AZOOR. Patients with AZOOR show partial recovery or stabilization even without treatment.&#x000a0;Multiple evanescent white dot syndrome (MEWDS) shows unilateral retinopathy associated with optic nerve edema,&#x000a0;afferent pupillary defect, and&#x000a0;spontaneous recovery.<xref ref-type="bibr" rid="article-143074.r117">[117]</xref><xref ref-type="bibr" rid="article-143074.r118">[118]</xref></p>
        <p><bold>Cone Dystrophy</bold>&#x000a0;</p>
        <p>In cone dystrophy, the rods usually remain normal or are at least partly spared, even during the late stages.<xref ref-type="bibr" rid="article-143074.r119">[119]</xref>&#x000a0;Features include dyschromatopsia, photophobia, loss&#x000a0;of visual acuity, and exclusive cone involvement in the ERG characterized by diminished or nonrecordable photopic ERGs and normal or reduced amplitudes in the scotopic ERGs.<xref ref-type="bibr" rid="article-143074.r120">[120]</xref></p>
        <p>
<bold>Toxic Retinopathy or Toxic Optic Neuropathy</bold>
</p>
        <p>In toxic retinopathy or toxic optic neuropathy, visual impairment occurs due to optic nerve damage caused by a toxin.<xref ref-type="bibr" rid="article-143074.r121">[121]</xref>&#x000a0;This entity can occur at any age, with both genders and all races being affected equally.&#x000a0;It mainly affects the ganglion cell axons, particularly the papillomacular nerve fiber bundle. Clinically, toxic&#x000a0;retinopathy or&#x000a0;toxic&#x000a0;optic&#x000a0;neuropathy presents as bilaterally symmetrical and progressive loss of vision with dyschromatopsia and the presence of central or cecocentral scotoma on visual fields.&#x000a0;Toxins causing retinopathy can be found in the blood, urine, and even hair.&#x000a0;The most common causes of toxic optic neuropathy include ethambutol, isoniazid, methanol, amiodarone, tobacco, and alcohol.<xref ref-type="bibr" rid="article-143074.r122">[122]</xref></p>
        <p>
<bold>Leber Hereditary Optic Neuropathy&#x000a0;</bold>
</p>
        <p>Leber hereditary optic neuropathy (LHON) is a rare mitochondrial disorder affecting young males&#x000a0;between 15 and 35 years of age. Sequential vision loss is seen in both eyes by optic neuropathy.<xref ref-type="bibr" rid="article-143074.r123">[123]</xref><xref ref-type="bibr" rid="article-143074.r124">[124]</xref>&#x000a0;It has a predominant maternal inheritance pattern.<xref ref-type="bibr" rid="article-143074.r125">[125]</xref>&#x000a0;Degeneration of the retinal ganglionic cells and their axons results in acute or subacute central vision loss.&#x000a0;Presymptomatic features include&#x000a0;telangiectatic vessels around the optic discs and variable degrees of retinal nerve fiber layer edema.<xref ref-type="bibr" rid="article-143074.r126">[126]</xref><xref ref-type="bibr" rid="article-143074.r127">[127]</xref>&#x000a0;</p>
        <p>Red&#x02013;green color vision abnormalities suggesting optic nerve dysfunction reduced contrast sensitivity, and subnormal visual electrophysiological parameters can also be seen.<xref ref-type="bibr" rid="article-143074.r128">[128]</xref>&#x000a0;In acute phases, central retinal vessel&#x000a0;tortuosity, retinal nerve fiber layer edema, and circumpapillary telangiectatic microangiopathy are seen.<xref ref-type="bibr" rid="article-143074.r129">[129]</xref>&#x000a0;The optic disc can appear normal in the acute phase in approximately 20% of cases.&#x000a0;The chronic phase is characterized by retinal nerve fiber layer degeneration and optic atrophy seen after&#x000a0;6 months after the onset of the condition.<xref ref-type="bibr" rid="article-143074.r130">[130]</xref></p>
        <p><bold>Nutritional Optic Neuropathy</bold>&#x000a0;</p>
        <p>In nutritional optic neuropathy, a visual impairment results from optic nerve damage occurring secondary to nutritional deficiency&#x000a0;(primarily a vitamin deficiency).&#x000a0;Deficiency of vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B3 (niacin), vitamin B6 (pyridoxine), vitamin B12 (cyanocobalamin), and folic acid is associated with nutritional optic neuropathy.&#x000a0;The clinical features and pathophysiology involved are similar to toxic retinopathy.&#x000a0;Nutritional optic neuropathy can present as a nonspecific retrobulbar optic neuropathy.<xref ref-type="bibr" rid="article-143074.r121">[121]</xref></p>
        <p>
<bold>BDUMP</bold>
</p>
        <p>BDUMP is a rare paraneoplastic disorder first described by&#x000a0;Machemer et al in 1966.<xref ref-type="bibr" rid="article-143074.r131">[131]</xref>&#x000a0;The term BDUMP was coined by Barr et al in 1982.<xref ref-type="bibr" rid="article-143074.r132">[132]</xref>&#x000a0;The usual age of presentation ranges between 34 to 89 years, with the median age being 64 years.<xref ref-type="bibr" rid="article-143074.r133">[133]</xref>&#x000a0;It presents with acute onset, rapid, bilateral (rarely unilateral),&#x000a0;and painless loss of visual acuity&#x000a0;with a female predilection.&#x000a0;The primary malignancy usually associated with BDUMP in females is&#x000a0;urogenital cancer (most commonly ovarian cancer),&#x000a0;and in males is lung cancer.<xref ref-type="bibr" rid="article-143074.r134">[134]</xref>&#x000a0;</p>
        <p>The cardinal signs of BDUMP, as described by Gass et al include multiple, subtle, round, or oval, orange&#x02013;red patches at the level of RPE;&#x000a0;multifocal early hyperfluorescence;&#x000a0;multiple, focally elevated, pigmented, and nonpigmented uveal melanocytic tumors with diffuse uveal tract thickening;&#x000a0;the presence of an exudative type of retinal detachment;&#x000a0;and rapid cataract progression.<xref ref-type="bibr" rid="article-143074.r135">[135]</xref>&#x000a0;Fundus autofluorescence usually shows nummular changes, giving a giraffe pattern with inverse changes compared to fluorescein angiogram.<xref ref-type="bibr" rid="article-143074.r136">[136]</xref></p>
        <p>Treatment options available for BDUMP include radiation therapy, the use of local and systemic corticosteroids,&#x000a0;plasmapheresis,&#x000a0;drainage of the subretinal fluid, and vitrectomy.&#x000a0;However, BDUMP has a very poor visual prognosis and survival rate. Most of the patients become legally blind within&#x000a0;1 year or succumb to death within&#x000a0;3 years of initial presentation secondary to the systemic malignancy.<xref ref-type="bibr" rid="article-143074.r137">[137]</xref>&#x000a0;</p>
        <p>
<bold>Chronic Central Serous Chorioretinopathy&#x000a0;</bold>
</p>
        <p>Chronic central serous chorioretinopathy (CSCR) is a retinal disorder seen in young males between the ages of 20&#x000a0;and 45 years.<xref ref-type="bibr" rid="article-143074.r138">[138]</xref>&#x000a0;It is usually unilateral; however, a bilateral presentation has been noted in 40% of cases.<xref ref-type="bibr" rid="article-143074.r139">[139]</xref> Chronic CSCR (or diffuse retinal epitheliopathy)&#x000a0;is characterized by the persistence of a well-defined, circular, or oval area of localized serous retinal detachment over the posterior pole beyond 3 to 6 months of initial presentation.&#x000a0;It can be seen in older patients or those on long-term steroid therapy.<xref ref-type="bibr" rid="article-143074.r140">[140]</xref>&#x000a0;</p>
        <p>Presenting complaints in acute CSCR include the presence of micropsia, blurring of vision, metamorphopsia, disturbances in color vision, relative scotoma, and temporary hyperopia.&#x000a0;whereas chronic form is associated with a more severe or even permanent loss of visual acuity.&#x000a0;The extent of visual damage depends on the damage to the photoreceptor-outer segments&#x000a0;and the external limiting membrane.<xref ref-type="bibr" rid="article-143074.r141">[141]</xref>&#x000a0;FAF in chronic CSCR shows vertical tracks in the inferior retina.<xref ref-type="bibr" rid="article-143074.r142">[142]</xref>&#x000a0;</p>
        <p>Patchy areas of hyperfluorescence (areas of RPE atrophy) can be seen on FFA. Optical coherence tomography (OCT) findings in chronic CSCR comprise elongation of photoreceptor outer segments, the presence of intraretinal cysts, and hyperreflective dots.<xref ref-type="bibr" rid="article-143074.r142">[142]</xref> Chronic CSCR with retinal pigment epithelial detachments can develop an RPE rip with secondary exudative retinal detachment.<xref ref-type="bibr" rid="article-143074.r142">[142]</xref>&#x000a0;</p>
        <p>
<bold>PON</bold>
</p>
        <p>PON is a rare paraneoplastic entity affecting middle-aged patients with malignancies, including thyroid cancer, thymoma, cervical cancer, testicular seminoma, and lung cancer.<xref ref-type="bibr" rid="article-143074.r143">[143]</xref>&#x000a0;It is characterized by bilateral, subacute, progressive, painless, and profound loss of visual acuity.<xref ref-type="bibr" rid="article-143074.r143">[143]</xref>&#x000a0;It is caused by the cross-reactivity of antibodies generated by the tumor-associated antigens with the neuronal and glial proteins.<xref ref-type="bibr" rid="article-143074.r144">[144]</xref>&#x000a0;The fundus examination reveals optic disc edema.<xref ref-type="bibr" rid="article-143074.r143">[143]</xref>&#x000a0;</p>
        <p>Other findings include an abnormal ERG,&#x000a0;visual field defects (tubular vision, enlargement of blind spot, and an inferior scotoma),&#x000a0;and visual evoked potential (VEP) changes (decreased amplitude and a delayed implicit period).<xref ref-type="bibr" rid="article-143074.r145">[145]</xref>&#x000a0;Important serological tests include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anti-Hu or antineuronal nuclear antibody type-1 (AANA-1)</p>
          </list-item>
          <list-item>
            <p>anti-Tr (anti-Purkinje cell antibody)</p>
          </list-item>
          <list-item>
            <p>anti-Yo (anti-Purkinje cell cytoplasmic antibody type 1)</p>
          </list-item>
          <list-item>
            <p>anti-CV2/CRMP5 (anti-collapsin response mediator protein-5)</p>
          </list-item>
          <list-item>
            <p>anti-Ri (antineuronal nuclear antibody type-2)</p>
          </list-item>
          <list-item>
            <p>anti-Ma2/TA (anti-PNMA2 or anti-paraneoplastic antigen Ma2),&#x000a0;and</p>
          </list-item>
          <list-item>
            <p>anti-amphiphysin&#x000a0;antibody testing.&#x000a0;</p>
          </list-item>
        </list>
        <p>Of&#x000a0;these, anti-Hu and&#x000a0;anti-CV2/CRMP5, antibodies are more consistently associated with paraneoplastic neuropathy.<xref ref-type="bibr" rid="article-143074.r146">[146]</xref><xref ref-type="bibr" rid="article-143074.r147">[147]</xref>&#x000a0;Antibodies to&#x000a0;aquaporin-4 antibody may be present.<xref ref-type="bibr" rid="article-143074.r143">[143]</xref></p>
        <p>PON leads to irreversible optic nerve changes, and hence,&#x000a0;the visual prognosis of PON remains poor as even immunosuppressive therapy and steroids have not been very effective in management.&#x000a0;Prompt treatment of the underlying malignancy is the only way to halt the progression of the disease.<xref ref-type="bibr" rid="article-143074.r148">[148]</xref>&#x000a0;</p>
        <p>
<bold>Vitamin A Deficiency</bold>
</p>
        <p>Vitamin A is a fat-soluble vitamin required for vision, overall cellular development, immunity, metabolism, and reproductive functions.<xref ref-type="bibr" rid="article-143074.r149">[149]</xref><xref ref-type="bibr" rid="article-143074.r150">[150]</xref>&#x000a0;The recommended dietary allowance (RDA) of vitamin A for an adult male is&#x000a0;900 mcg/day, and for an adult female is 700 mcg/day.<xref ref-type="bibr" rid="article-143074.r151">[151]</xref>&#x000a0;The RDA of vitamin A for&#x000a0;children is 300 to 900 mcg/day; for pregnant and lactating women, it is 770 mcg/day and 1300 mcg/day, respectively.<xref ref-type="bibr" rid="article-143074.r152">[152]</xref>&#x000a0;</p>
        <p>Serum retinol concentrations of less than 20 mcg/dL are regarded as vitamin A deficiency.&#x000a0;Ocular symptoms of vitamin A deficiency develop when the serum retinol concentration drops below&#x000a0;10 mcg/dL.<xref ref-type="bibr" rid="article-143074.r153">[153]</xref>&#x000a0;It usually occurs following malabsorption, infections, or poor nutrition.&#x000a0;Night blindness or nyctalopia is the first presenting feature of vitamin A deficiency&#x000a0;caused by profound rod dysfunction.&#x000a0;Fundus examination may reveal multiple white or grey-white spots or dots in the peripheral retina (Uyemura fundus).<xref ref-type="bibr" rid="article-143074.r154">[154]</xref>&#x000a0;</p>
        <p>ERG shows undetectable or reduced rod response with reduced amplitudes and increased latency of cone response. OCT may show hyperreflective elevated lesions just below the ellipsoid zone corresponding to the white dots.<xref ref-type="bibr" rid="article-143074.r155">[155]</xref>&#x000a0;Other early external ocular findings include&#x000a0;Bitot spots (oval or triangular, foamy lesions of the conjunctiva) and conjunctival xerosis (wrinkling of the conjunctiva).&#x000a0;Late signs of vitamin A deficiency, such as corneal xerosis, corneal ulceration, and, eventually, keratomalacia, may lead to permanent visual damage.&#x000a0;Prompt management of vitamin A deficiency at a subclinical stage has a very good prognosis.<xref ref-type="bibr" rid="article-143074.r152">[152]</xref>&#x000a0;Permanent vision loss or blindness may be seen in the case of severe vitamin A deficiency.<xref ref-type="bibr" rid="article-143074.r156">[156]</xref></p>
        <p>Hence, to diagnose CAR, it is important to correlate the findings of the sera with the electroretinogram and clinical features with due help from other investigative modalities.</p>
      </sec>
      <sec id="article-143074.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Visual decline and even loss of visual acuity due to CAR may occur even before the diagnosis of cancer.&#x000a0;When CAR is associated with recoverin antibodies, the condition can progress to profound vision loss to even no perception of light.<xref ref-type="bibr" rid="article-143074.r63">[63]</xref>&#x000a0;Early diagnosis and initiation of treatment are prerequisites for the preservation of vision.&#x000a0;However, a targeted decimation of the photoreceptors and the support cells occurs; thus, despite even immunomodulatory therapy, the visual prognosis remains poor.&#x000a0;Hence, in any patient, if there is an acute or subacute loss of visual acuity, visual field alterations, and vascular attenuation in the fundus without any other etiology, a suspicion for CAR should be made.&#x000a0;Visual prognosis is not affected by the treatment of underlying cancer.&#x000a0;Overall survival of the patient depends upon the underlying tumor and stage at which it was diagnosed and the available treatment options.<xref ref-type="bibr" rid="article-143074.r157">[157]</xref>&#x000a0;</p>
        <p>Adamus et al, after&#x000a0;examining 209 cancer patients, concluded that patients who are at risk for developing CAR could be identified early using the antiretinal autoantibodies.<xref ref-type="bibr" rid="article-143074.r158">[158]</xref>&#x000a0;This early detection may prevent vision loss in such vulnerable patients.</p>
      </sec>
      <sec id="article-143074.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Choroidal neovascularization can occur secondary to CAR.<xref ref-type="bibr" rid="article-143074.r53">[53]</xref>&#x000a0;Other causes of vision loss in patients with CAR include cataracts, macular edema,&#x000a0;foveal thinning, and secondary optic atrophy.<xref ref-type="bibr" rid="article-143074.r65">[65]</xref>&#x000a0;The mortality depends on the cause of CAR, and the primary malignancy should be managed optimally.</p>
      </sec>
      <sec id="article-143074.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with&#x000a0;CAR need proper guidance, in-depth evaluation, and&#x000a0;education about&#x000a0;this condition and the various treatment options available. Patients need to understand that CAR is a potentially blinding and devastating condition, and the features of the same may develop even before the neoplasm is clinically evident.&#x000a0;Further,&#x000a0;patients must&#x000a0;understand that although there is no standard treatment protocol for this entity, proper compliance with the treatment is needed to stall or rarely reverse this condition.<xref ref-type="bibr" rid="article-143074.r35">[35]</xref></p>
      </sec>
      <sec id="article-143074.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>A comprehensive approach is crucial for managing patients with CAR. An appropriately high index of suspicion and early diagnosis and treatment play an imperative role in curtailing the risk of irreversible immunological damage to the retinal cells in these patients. Hence, a multidisciplinary approach for complete evaluation and treatment is vital for properly managing this condition, even though there is no consensus on the standard treatment protocol. For instance, when a patient is suspected of having CAR, a prompt referral by the treating physician or oncologist to the ophthalmologist is recommended. This is to be followed by collaborative planning between the oncologist, ophthalmologist, rheumatologist, dermatologist, radiologist, or even a uveitis specialist accustomed to administering the immunomodulatory agents.</p>
        <p>The interprofessional teamwork required to treat this condition includes evaluation by the physician/clinician or oncologist, the ophthalmologist, dispensing of medicines&#x000a0;by the pharmacist, aiding in patient education for treatment compliance as well as monitoring the vitals by the nurses, and thorough evaluation of the visual acuity by the optometrist. This united interprofessional approach is decisive in managing the patients and acquiring favorable outcomes.&#x000a0;</p>
      </sec>
      <sec id="article-143074.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=143074&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=143074">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/cancer-associated-retinopathy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=143074">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/143074/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=143074">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-143074.s16">
        <fig id="article-143074.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Cancer-Associated Retinopathy. Multicolor fundus images of the right and the left eye show retinal pigmentary changes seen during the early phase of cancer-associated retinopathy.&#x000a0;Optical coherence tomography (OCT) of both eyes shows the absence of the ellipsoid zone (EZ) outside the fovea with thinning of the photoreceptor layer. Contributed by Koushik Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IMG-20211224-WA000589" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-143074.s17">
        <title>References</title>
        <ref id="article-143074.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thirkill</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Keltner</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Cancer-associated retinopathy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1987</year>
            <month>Mar</month>
            <volume>105</volume>
            <issue>3</issue>
            <fpage>372</fpage>
            <page-range>372-5</page-range>
            <pub-id pub-id-type="pmid">2950846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keltner</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Thirkill</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Tyler</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Management and monitoring of cancer-associated retinopathy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1992</year>
            <month>Jan</month>
            <volume>110</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-53</page-range>
            <pub-id pub-id-type="pmid">1310001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thirkill</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>FitzGerald</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sergott</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tyler</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Keltner</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells.</article-title>
            <source>N Engl J Med</source>
            <year>1989</year>
            <month>Dec</month>
            <day>07</day>
            <volume>321</volume>
            <issue>23</issue>
            <fpage>1589</fpage>
            <page-range>1589-94</page-range>
            <pub-id pub-id-type="pmid">2555714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heckenlively</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Ferreyra</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune retinopathy: a review and summary.</article-title>
            <source>Semin Immunopathol</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <page-range>127-34</page-range>
            <pub-id pub-id-type="pmid">18408929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dutta Majumder</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marchese</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pichi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>An update on autoimmune retinopathy.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>68</volume>
            <issue>9</issue>
            <fpage>1829</fpage>
            <page-range>1829-1837</page-range>
            <pub-id pub-id-type="pmid">32823399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sawyer</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Selhorst</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Hoyt</surname>
                <given-names>WF</given-names>
              </name>
            </person-group>
            <article-title>Blindness caused by photoreceptor degeneration as a remote effect of cancer.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1976</year>
            <month>May</month>
            <volume>81</volume>
            <issue>5</issue>
            <fpage>606</fpage>
            <page-range>606-13</page-range>
            <pub-id pub-id-type="pmid">179323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klingele</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Burde</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Rappazzo</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Isserman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Burgess</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kantor</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic retinopathy.</article-title>
            <source>J Clin Neuroophthalmol</source>
            <year>1984</year>
            <month>Dec</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>239</fpage>
            <page-range>239-45</page-range>
            <pub-id pub-id-type="pmid">6240497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mizener</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Thirkill</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Goeken</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kardon</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune retinopathy in the absence of cancer.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1997</year>
            <month>May</month>
            <volume>123</volume>
            <issue>5</issue>
            <fpage>607</fpage>
            <page-range>607-18</page-range>
            <pub-id pub-id-type="pmid">9152066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henry</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment.</article-title>
            <source>Semin Diagn Pathol</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>204</fpage>
            <page-range>204-210</page-range>
            <pub-id pub-id-type="pmid">30876820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naramala</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Adapa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gavini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Konala</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Case Series of Cancer-associated Retinopathy (CAR).</article-title>
            <source>Cureus</source>
            <year>2019</year>
            <month>Jun</month>
            <day>10</day>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>e4872</fpage>
            <pub-id pub-id-type="pmid">31417817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keltner</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Photoreceptor degeneration. Possible autoimmune disorder.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1983</year>
            <month>Apr</month>
            <volume>101</volume>
            <issue>4</issue>
            <fpage>564</fpage>
            <page-range>564-9</page-range>
            <pub-id pub-id-type="pmid">6838414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katsuta</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakauchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yamao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uchida</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cancer-associated retinopathy associated with invasive thymoma.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>134</volume>
            <issue>3</issue>
            <fpage>383</fpage>
            <page-range>383-9</page-range>
            <pub-id pub-id-type="pmid">12208250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic retinopathies and optic neuropathies.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2003</year>
            <season>Jan-Feb</season>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-38</page-range>
            <pub-id pub-id-type="pmid">12559325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guigay</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>139</volume>
            <issue>4</issue>
            <fpage>746</fpage>
            <page-range>746-7</page-range>
            <pub-id pub-id-type="pmid">15808190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.</article-title>
            <source>Autoimmun Rev</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>410</fpage>
            <page-range>410-4</page-range>
            <pub-id pub-id-type="pmid">19168157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misiuk-Hoj&#x00142;o</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ejma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gorczyca</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Szymaniec</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Witkowska</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fortuna</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Miedzybrodzki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rogozi&#x00144;ska-Szczepka</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bartnik</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Cancer-associated retinopathy in patients with breast carcinoma.</article-title>
            <source>Arch Immunol Ther Exp (Warsz)</source>
            <year>2007</year>
            <season>Jul-Aug</season>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>261</fpage>
            <page-range>261-5</page-range>
            <pub-id pub-id-type="pmid">17659379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raghunath</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bodurka</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schiffman</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Cancer-associated retinopathy in neuroendocrine carcinoma of the fallopian tube.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>252</fpage>
            <page-range>252-4</page-range>
            <pub-id pub-id-type="pmid">20724944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Mallory</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Armbrust</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Trautman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Montezuma</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Cancer-Associated Retinopathy due to Clear Cell Renal Carcinoma.</article-title>
            <source>Ocul Oncol Pathol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-35</page-range>
            <pub-id pub-id-type="pmid">33796514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsui</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Katsumi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Brodie</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Hirose</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Electrophysiological findings in paraneoplastic retinopathy.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>1992</year>
            <volume>230</volume>
            <issue>4</issue>
            <fpage>324</fpage>
            <page-range>324-8</page-range>
            <pub-id pub-id-type="pmid">1505762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grange</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dalal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>HN</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune retinopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>157</volume>
            <issue>2</issue>
            <fpage>266</fpage>
            <page-range>266-272.e1</page-range>
            <pub-id pub-id-type="pmid">24315290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Honnorat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Antoine</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic neurological syndromes.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2007</year>
            <month>May</month>
            <day>04</day>
            <volume>2</volume>
            <fpage>22</fpage>
            <pub-id pub-id-type="pmid">17480225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braithwaite</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vugler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tufail</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune retinopathy.</article-title>
            <source>Ophthalmologica</source>
            <year>2012</year>
            <volume>228</volume>
            <issue>3</issue>
            <fpage>131</fpage>
            <page-range>131-42</page-range>
            <pub-id pub-id-type="pmid">22846442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Weleber</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2004</year>
            <month>Jun</month>
            <day>04</day>
            <volume>4</volume>
            <fpage>5</fpage>
            <pub-id pub-id-type="pmid">15180904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keltner</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Thirkill</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Yip</surname>
                <given-names>PT</given-names>
              </name>
            </person-group>
            <article-title>Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>173</fpage>
            <page-range>173-87</page-range>
            <pub-id pub-id-type="pmid">11725182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carrera</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Tsamis</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A case of cancer-associated retinopathy with chorioretinitis and optic neuritis associated with occult small cell lung cancer.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2019</year>
            <month>May</month>
            <day>02</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <pub-id pub-id-type="pmid">31046716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thirkill</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Tait</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Tyler</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Keltner</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>The cancer-associated retinopathy antigen is a recoverin-like protein.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>33</volume>
            <issue>10</issue>
            <fpage>2768</fpage>
            <page-range>2768-72</page-range>
            <pub-id pub-id-type="pmid">1388144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohguro</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yokoi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ohguro</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mamiya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yamazaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Metoki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical and immunologic aspects of cancer-associated retinopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>137</volume>
            <issue>6</issue>
            <fpage>1117</fpage>
            <page-range>1117-9</page-range>
            <pub-id pub-id-type="pmid">15183799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGinnis</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Stepanik</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Baehr</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Subbaraya</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lerious</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Cloning and sequencing of the 23 kDa mouse photoreceptor cell-specific protein.</article-title>
            <source>FEBS Lett</source>
            <year>1992</year>
            <month>May</month>
            <day>11</day>
            <volume>302</volume>
            <issue>2</issue>
            <fpage>172</fpage>
            <page-range>172-6</page-range>
            <pub-id pub-id-type="pmid">1386025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polans</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Witkowska</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Haley</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Amundson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baizer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1995</year>
            <month>Sep</month>
            <day>26</day>
            <volume>92</volume>
            <issue>20</issue>
            <fpage>9176</fpage>
            <page-range>9176-80</page-range>
            <pub-id pub-id-type="pmid">7568096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Amundson</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Epitope recognition of recoverin in cancer associated retinopathy: evidence for calcium-dependent conformational epitopes.</article-title>
            <source>J Neurosci Res</source>
            <year>1996</year>
            <month>Sep</month>
            <day>15</day>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>863</fpage>
            <page-range>863-72</page-range>
            <pub-id pub-id-type="pmid">8892098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Machnicki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seigel</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>283</fpage>
            <page-range>283-91</page-range>
            <pub-id pub-id-type="pmid">9040460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maeda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maruyama</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Kuroki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sahara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ohguro</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of photoreceptor cell death in cancer-associated retinopathy.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>705</fpage>
            <page-range>705-12</page-range>
            <pub-id pub-id-type="pmid">11222531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Xue</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hedlund</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Tritsaris</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tondelli</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lucchini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Dissing</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2010</year>
            <month>Jan</month>
            <day>12</day>
            <volume>107</volume>
            <issue>2</issue>
            <fpage>856</fpage>
            <page-range>856-61</page-range>
            <pub-id pub-id-type="pmid">20080765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Obara</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ichiwata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Uchiyama</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Cancer-associated retinopathy with presumed vasculitis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>122</volume>
            <issue>1</issue>
            <fpage>125</fpage>
            <page-range>125-7</page-range>
            <pub-id pub-id-type="pmid">8659589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shildkrot</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sobrin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gragoudas</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Cancer-associated retinopathy: update on pathogenesis and therapy.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2011</year>
            <season>Jul-Sep</season>
            <volume>26</volume>
            <issue>4-5</issue>
            <fpage>321</fpage>
            <page-range>321-8</page-range>
            <pub-id pub-id-type="pmid">21958182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ortega</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Witkowska</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Polans</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Recoverin: a potent uveitogen for the induction of photoreceptor degeneration in Lewis rats.</article-title>
            <source>Exp Eye Res</source>
            <year>1994</year>
            <month>Oct</month>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>447</fpage>
            <page-range>447-55</page-range>
            <pub-id pub-id-type="pmid">7859820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohguro</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Maruyama</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Takano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>42</volume>
            <issue>11</issue>
            <fpage>2589</fpage>
            <page-range>2589-95</page-range>
            <pub-id pub-id-type="pmid">11581204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGinnis</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Klisak</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Heinzmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kojis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sparkes</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Bateman</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Lerious</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Chromosomal assignment of the human gene for the cancer-associated retinopathy protein (recoverin) to chromosome 17p13.1.</article-title>
            <source>J Neurosci Res</source>
            <year>1995</year>
            <month>Feb</month>
            <day>01</day>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>165</fpage>
            <page-range>165-8</page-range>
            <pub-id pub-id-type="pmid">7745609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bazhin</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>De Smet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Golovastova</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Philippov</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <article-title>Aberrant demethylation of the recoverin gene is involved in the aberrant expression of recoverin in cancer cells.</article-title>
            <source>Exp Dermatol</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>11</issue>
            <fpage>1023</fpage>
            <page-range>1023-5</page-range>
            <pub-id pub-id-type="pmid">20812967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bazhin</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Shifrina</surname>
                <given-names>ON</given-names>
              </name>
              <name>
                <surname>Savchenko</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Tikhomirova</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Goncharskaia</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gorbunova</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Senin</surname>
                <given-names>II</given-names>
              </name>
              <name>
                <surname>Chuchalin</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Philippov</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <article-title>Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision.</article-title>
            <source>Lung Cancer</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-104</page-range>
            <pub-id pub-id-type="pmid">11557119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobayashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ikezoe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Uemura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ueno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Taguchi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Long-term survival of a patient with small cell lung cancer associated with cancer-associated retinopathy.</article-title>
            <source>Lung Cancer</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>57</volume>
            <issue>3</issue>
            <fpage>399</fpage>
            <page-range>399-403</page-range>
            <pub-id pub-id-type="pmid">17397962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bazhin</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Savchenko</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Shifrina</surname>
                <given-names>ON</given-names>
              </name>
              <name>
                <surname>Demoura</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Chikina</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Jaques</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kogan</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Chuchalin</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Philippov</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <article-title>Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.</article-title>
            <source>Lung Cancer</source>
            <year>2004</year>
            <month>May</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-8</page-range>
            <pub-id pub-id-type="pmid">15084384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maeda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ohguro</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Palczewski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice.</article-title>
            <source>Eur J Immunol</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>8</issue>
            <fpage>2300</fpage>
            <page-range>2300-7</page-range>
            <pub-id pub-id-type="pmid">12209643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Weleber</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Molecular biomarkers for autoimmune retinopathies: significance of anti-transducin-alpha autoantibodies.</article-title>
            <source>Exp Mol Pathol</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>87</volume>
            <issue>3</issue>
            <fpage>195</fpage>
            <page-range>195-203</page-range>
            <pub-id pub-id-type="pmid">19744478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Aptsiauri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Guy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Heckenlively</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Flannery</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hargrave</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy.</article-title>
            <source>Clin Immunol Immunopathol</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>78</volume>
            <issue>2</issue>
            <fpage>120</fpage>
            <page-range>120-9</page-range>
            <pub-id pub-id-type="pmid">8625554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magrys</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Anekonda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy.</article-title>
            <source>J Clin Immunol</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>181</fpage>
            <page-range>181-92</page-range>
            <pub-id pub-id-type="pmid">17235687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grewal</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Jampol</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune retinopathy and antiretinal antibodies: a review.</article-title>
            <source>Retina</source>
            <year>2014</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>827</fpage>
            <page-range>827-45</page-range>
            <pub-id pub-id-type="pmid">24646664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forooghian</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sproule</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Westall</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Enolase autoantibodies and retinal function in multiple sclerosis patients.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>245</volume>
            <issue>8</issue>
            <fpage>1077</fpage>
            <page-range>1077-84</page-range>
            <pub-id pub-id-type="pmid">17219105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terrier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Degand</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Guilpain</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Servettaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guillevin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mouthon</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Alpha-enolase: a target of antibodies in infectious and autoimmune diseases.</article-title>
            <source>Autoimmun Rev</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>176</fpage>
            <page-range>176-82</page-range>
            <pub-id pub-id-type="pmid">17289554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pratesi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Moscato</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sabbatini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chimenti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bombardieri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Migliorini</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Autoantibodies specific for alpha-enolase in systemic autoimmune disorders.</article-title>
            <source>J Rheumatol</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>109</fpage>
            <page-range>109-15</page-range>
            <pub-id pub-id-type="pmid">10648026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohguro</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>1999</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>82</fpage>
            <page-range>82-9</page-range>
            <pub-id pub-id-type="pmid">9888430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Karren</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy.</article-title>
            <source>J Autoimmun</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>133</fpage>
            <page-range>133-9</page-range>
            <pub-id pub-id-type="pmid">19269136</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Querques</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Thirkill</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Hagege</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Soubrane</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Souied</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Choroidal neovascularization associated with cancer-associated retinopathy.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>88</volume>
            <issue>5</issue>
            <fpage>571</fpage>
            <page-range>571-5</page-range>
            <pub-id pub-id-type="pmid">19141145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kikuchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Arai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shibuki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawashima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yoshimura</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy.</article-title>
            <source>J Neuroimmunol</source>
            <year>2000</year>
            <month>Feb</month>
            <day>01</day>
            <volume>103</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-33</page-range>
            <pub-id pub-id-type="pmid">10674986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maeda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yenerel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saperstein</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen.</article-title>
            <source>Mol Vis</source>
            <year>2006</year>
            <month>Aug</month>
            <day>10</day>
            <volume>12</volume>
            <fpage>885</fpage>
            <page-range>885-91</page-range>
            <pub-id pub-id-type="pmid">16917481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gough</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Sansom</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>CTLA4 gene polymorphism and autoimmunity.</article-title>
            <source>Immunol Rev</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>204</volume>
            <fpage>102</fpage>
            <page-range>102-15</page-range>
            <pub-id pub-id-type="pmid">15790353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Serrano</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Millan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>P&#x000e1;ez</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Non-HLA associations with autoimmune diseases.</article-title>
            <source>Autoimmun Rev</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>209</fpage>
            <page-range>209-14</page-range>
            <pub-id pub-id-type="pmid">16483921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizzo</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Gittinger</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome.</article-title>
            <source>Ophthalmology</source>
            <year>1992</year>
            <month>Aug</month>
            <volume>99</volume>
            <issue>8</issue>
            <fpage>1286</fpage>
            <page-range>1286-95</page-range>
            <pub-id pub-id-type="pmid">1325045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schmied</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Arendt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hargrave</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Role of anti-recoverin autoantibodies in cancer-associated retinopathy.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>1993</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>9</issue>
            <fpage>2626</fpage>
            <page-range>2626-33</page-range>
            <pub-id pub-id-type="pmid">7688357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Almeida</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Chin</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Niles</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kardon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sohn</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Unilateral manifestation of autoimmune retinopathy.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>e85</fpage>
            <page-range>e85-7</page-range>
            <pub-id pub-id-type="pmid">25103665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohguro</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Maruyama</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oohira</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Antirecoverin antibody in the aqueous humor of a patient with cancer-associated retinopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>134</volume>
            <issue>4</issue>
            <fpage>605</fpage>
            <page-range>605-7</page-range>
            <pub-id pub-id-type="pmid">12383822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whitcup</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Vistica</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Milam</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Gery</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>126</volume>
            <issue>2</issue>
            <fpage>230</fpage>
            <page-range>230-7</page-range>
            <pub-id pub-id-type="pmid">9727517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weleber</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Watzke</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Shults</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Trzupek</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Heckenlively</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Egan</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2005</year>
            <month>May</month>
            <volume>139</volume>
            <issue>5</issue>
            <fpage>780</fpage>
            <page-range>780-94</page-range>
            <pub-id pub-id-type="pmid">15860281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saito</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kase</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ohguro</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Furudate</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ohno</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Slowly progressive cancer-associated retinopathy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>125</volume>
            <issue>10</issue>
            <fpage>1431</fpage>
            <page-range>1431-3</page-range>
            <pub-id pub-id-type="pmid">17923561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Thirkill</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Tipping</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>A clinical triad to diagnose paraneoplastic retinopathy.</article-title>
            <source>Ann Neurol</source>
            <year>1990</year>
            <month>Aug</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>162</fpage>
            <page-range>162-7</page-range>
            <pub-id pub-id-type="pmid">2171418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>YY</given-names>
              </name>
            </person-group>
            <article-title>Increased risk of cancer in patients with early-onset cataracts: a nationwide population-based study.</article-title>
            <source>Cancer Sci</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>105</volume>
            <issue>4</issue>
            <fpage>431</fpage>
            <page-range>431-6</page-range>
            <pub-id pub-id-type="pmid">24450445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klaunig</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kamendulis</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Hocevar</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Oxidative stress and oxidative damage in carcinogenesis.</article-title>
            <source>Toxicol Pathol</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>96</fpage>
            <page-range>96-109</page-range>
            <pub-id pub-id-type="pmid">20019356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michael</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bron</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>The ageing lens and cataract: a model of normal and pathological ageing.</article-title>
            <source>Philos Trans R Soc Lond B Biol Sci</source>
            <year>2011</year>
            <month>Apr</month>
            <day>27</day>
            <volume>366</volume>
            <issue>1568</issue>
            <fpage>1278</fpage>
            <page-range>1278-92</page-range>
            <pub-id pub-id-type="pmid">21402586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r69">
          <label>69</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ruia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Humphrey Visual Field</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">36256759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lima</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Greenstein</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Sallum</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Thirkill</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Tsang</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Hyperautofluorescent ring in autoimmune retinopathy.</article-title>
            <source>Retina</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>7</issue>
            <fpage>1385</fpage>
            <page-range>1385-94</page-range>
            <pub-id pub-id-type="pmid">22218149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eldred</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Fluorophores of the human retinal pigment epithelium: separation and spectral characterization.</article-title>
            <source>Exp Eye Res</source>
            <year>1988</year>
            <month>Jul</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-86</page-range>
            <pub-id pub-id-type="pmid">3409988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>von R&#x000fc;ckmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fitzke</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Distribution of fundus autofluorescence with a scanning laser ophthalmoscope.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1995</year>
            <month>May</month>
            <volume>79</volume>
            <issue>5</issue>
            <fpage>407</fpage>
            <page-range>407-12</page-range>
            <pub-id pub-id-type="pmid">7612549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennedy</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Rakoczy</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Constable</surname>
                <given-names>IJ</given-names>
              </name>
            </person-group>
            <article-title>Lipofuscin of the retinal pigment epithelium: a review.</article-title>
            <source>Eye (Lond)</source>
            <year>1995</year>
            <volume>9 ( Pt 6)</volume>
            <fpage>763</fpage>
            <page-range>763-71</page-range>
            <pub-id pub-id-type="pmid">8849547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aguirre-Lamban</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Riveiro-Alvarez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maia-Lopes</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cantalapiedra</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vallespin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Avila-Fernandez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Villaverde-Montero</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Trujillo-Tiebas</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ramos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ayuso</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Molecular analysis of the ABCA4 gene for reliable detection of allelic variations in Spanish patients: identification of 21 novel variants.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2009</year>
            <month>May</month>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>614</fpage>
            <page-range>614-21</page-range>
            <pub-id pub-id-type="pmid">19028736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsang</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Vaclavik</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Robson</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Holder</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Novel phenotypic and genotypic findings in X-linked retinoschisis.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>125</volume>
            <issue>2</issue>
            <fpage>259</fpage>
            <page-range>259-67</page-range>
            <pub-id pub-id-type="pmid">17296904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scholl</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Robson</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Holder</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Fundus autofluorescence in patients with leber congenital amaurosis.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>45</volume>
            <issue>8</issue>
            <fpage>2747</fpage>
            <page-range>2747-52</page-range>
            <pub-id pub-id-type="pmid">15277500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pichi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Abboud</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Ghazi</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>AO</given-names>
              </name>
            </person-group>
            <article-title>Fundus autofluorescence imaging in hereditary retinal diseases.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>96</volume>
            <issue>5</issue>
            <fpage>e549</fpage>
            <page-range>e549-e561</page-range>
            <pub-id pub-id-type="pmid">29098804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murakami</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Akimoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ooto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ikeda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawagoe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoshimura</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Association between abnormal autofluorescence and photoreceptor disorganization in retinitis pigmentosa.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>145</volume>
            <issue>4</issue>
            <fpage>687</fpage>
            <page-range>687-94</page-range>
            <pub-id pub-id-type="pmid">18242574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r79">
          <label>79</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ruia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Fluorescein Angiography</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35015403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pepple</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Cusick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jaffe</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Mruthyunjaya</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>SD-OCT and autofluorescence characteristics of autoimmune retinopathy.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>97</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-44</page-range>
            <pub-id pub-id-type="pmid">23221966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abazari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Allam</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ghazi</surname>
                <given-names>NG</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography findings in autoimmune retinopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>153</volume>
            <issue>4</issue>
            <fpage>750</fpage>
            <page-range>750-6, 756.e1</page-range>
            <pub-id pub-id-type="pmid">22245461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sepah</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Sadiq</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanout</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Soliman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Afridi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coupland</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>QD</given-names>
              </name>
            </person-group>
            <article-title>Assessment of Retinal Structural and Functional Characteristics in Eyes with Autoimmune Retinopathy.</article-title>
            <source>Curr Mol Med</source>
            <year>2015</year>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>578</fpage>
            <page-range>578-86</page-range>
            <pub-id pub-id-type="pmid">26238366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khanna</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oakey</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Mititelu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases.</article-title>
            <source>J Ophthalmic Inflamm Infect</source>
            <year>2019</year>
            <month>Feb</month>
            <day>26</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">30806850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finn</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Stinnett</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Keenan</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Grewal</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Jaffe</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>256</volume>
            <issue>10</issue>
            <fpage>1867</fpage>
            <page-range>1867-1873</page-range>
            <pub-id pub-id-type="pmid">30128606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Igarashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sawamura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kaburaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aihara</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cancer-associated Retinopathy Developing After 10 Years of Complete Breast Cancer Remission.</article-title>
            <source>Neuroophthalmology</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-42</page-range>
            <pub-id pub-id-type="pmid">30723523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neena</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Anantharaman</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Antony</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma -associated Retinopathy(CAR): Role of Electroretinography(ERG) and Optical coherence Tomography(OCT) in diagnosis and predicting treatment outcome.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>21</volume>
            <fpage>101008</fpage>
            <pub-id pub-id-type="pmid">33511304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holopigian</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hood</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Electrophysiology.</article-title>
            <source>Ophthalmol Clin North Am</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>237</fpage>
            <page-range>237-51</page-range>
            <pub-id pub-id-type="pmid">12809161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wachtmeister</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Oscillatory potentials in the retina: what do they reveal.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>485</fpage>
            <page-range>485-521</page-range>
            <pub-id pub-id-type="pmid">9777648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Link</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schl&#x000f6;tzer-Schrehardt</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>J&#x000fc;nemann</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma-associated retinopathy-an electrophysiological and immunohistochemical correlation.</article-title>
            <source>Retina</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-72</page-range>
            <pub-id pub-id-type="pmid">18728619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goetgebuer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kestelyn-Stevens</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>De Laey</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kestelyn</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leroy</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Cancer-associated retinopathy (CAR) with electronegative ERG: a case report.</article-title>
            <source>Doc Ophthalmol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>116</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-55</page-range>
            <pub-id pub-id-type="pmid">17721792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohamed</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Acute optical coherence tomographic findings in cancer-associated retinopathy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>125</volume>
            <issue>8</issue>
            <fpage>1132</fpage>
            <page-range>1132-3</page-range>
            <pub-id pub-id-type="pmid">17698766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kornguth</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Appen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Choate</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung.</article-title>
            <source>Cancer</source>
            <year>1982</year>
            <month>Oct</month>
            <day>01</day>
            <volume>50</volume>
            <issue>7</issue>
            <fpage>1289</fpage>
            <page-range>1289-93</page-range>
            <pub-id pub-id-type="pmid">6286090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ko</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Brinton</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brinton</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Folk</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Mullins</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Seroreactivity against aqueous-soluble and detergent-soluble retinal proteins in posterior uveitis.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>129</volume>
            <issue>4</issue>
            <fpage>415</fpage>
            <page-range>415-20</page-range>
            <pub-id pub-id-type="pmid">21482867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forooghian</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Matsubara</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>The enigma of autoimmune retinopathy.</article-title>
            <source>Int Ophthalmol Clin</source>
            <year>2015</year>
            <season>Spring</season>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>81</fpage>
            <page-range>81-91</page-range>
            <pub-id pub-id-type="pmid">25730621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murphy</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Thirkill</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.</article-title>
            <source>J Neuroophthalmol</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-83</page-range>
            <pub-id pub-id-type="pmid">9176775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huynh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shildkrot</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lobo</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sobrin</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy.</article-title>
            <source>J Ophthalmic Inflamm Infect</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>169</fpage>
            <page-range>169-71</page-range>
            <pub-id pub-id-type="pmid">22415770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Javaid</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Rehan</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Al-Bermani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Unilateral cancer-associated retinopathy: a case report.</article-title>
            <source>Scott Med J</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>155</fpage>
            <page-range>155-159</page-range>
            <pub-id pub-id-type="pmid">26246524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferreyra</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Jayasundera</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Heckenlively</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Management of autoimmune retinopathies with immunosuppression.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>127</volume>
            <issue>4</issue>
            <fpage>390</fpage>
            <page-range>390-7</page-range>
            <pub-id pub-id-type="pmid">19365013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobzone</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cochard-Marianowski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kupfer</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bettembourg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dordain</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Misery</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cochener</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sassolas</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings.</article-title>
            <source>Arch Dermatol</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>140</volume>
            <issue>10</issue>
            <fpage>1258</fpage>
            <page-range>1258-61</page-range>
            <pub-id pub-id-type="pmid">15492190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aptsiauri</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1999</year>
            <month>Apr</month>
            <volume>117</volume>
            <issue>4</issue>
            <fpage>471</fpage>
            <page-range>471-7</page-range>
            <pub-id pub-id-type="pmid">10206574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahdi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Faia</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Goodwin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>HN</given-names>
              </name>
            </person-group>
            <article-title>A case of autoimmune retinopathy associated with thyroid carcinoma.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>322</fpage>
            <page-range>322-3</page-range>
            <pub-id pub-id-type="pmid">20662664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davoudi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ebrahimiadib</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yasa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sevgi</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Roohipoor</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Papavasilieou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Comander</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sobrin</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Outcomes in Autoimmune Retinopathy Patients Treated With Rituximab.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>180</volume>
            <fpage>124</fpage>
            <page-range>124-132</page-range>
            <pub-id pub-id-type="pmid">28483493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Machnicki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Elerding</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sugden</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blocker</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.</article-title>
            <source>J Autoimmun</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>523</fpage>
            <page-range>523-33</page-range>
            <pub-id pub-id-type="pmid">9802939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shiraga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Duvoisin</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells.</article-title>
            <source>J Autoimmun</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>146</fpage>
            <page-range>146-53</page-range>
            <pub-id pub-id-type="pmid">16426815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sugden</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Shiraga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Timmers</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hauswirth</surname>
                <given-names>WW</given-names>
              </name>
            </person-group>
            <article-title>Anti-apoptotic effects of CNTF gene transfer on photoreceptor degeneration in experimental antibody-induced retinopathy.</article-title>
            <source>J Autoimmun</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>121</fpage>
            <page-range>121-9</page-range>
            <pub-id pub-id-type="pmid">12935781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fishman</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Retinitis pigmentosa. Visual loss.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1978</year>
            <month>Jul</month>
            <volume>96</volume>
            <issue>7</issue>
            <fpage>1185</fpage>
            <page-range>1185-8</page-range>
            <pub-id pub-id-type="pmid">307377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fishman</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Farber</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Derlacki</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>X-linked retinitis pigmentosa. Profile of clinical findings.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1988</year>
            <month>Mar</month>
            <volume>106</volume>
            <issue>3</issue>
            <fpage>369</fpage>
            <page-range>369-75</page-range>
            <pub-id pub-id-type="pmid">3257866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heckenlively</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Aptsiauri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nusinowitz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hargrave</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>1996</year>
            <volume>94</volume>
            <fpage>179</fpage>
            <page-range>179-200; discussion 200-6</page-range>
            <pub-id pub-id-type="pmid">8981696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takeuchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Usui</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Okunuki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yamakawa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kezuka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>6</issue>
            <fpage>3067</fpage>
            <page-range>3067-75</page-range>
            <pub-id pub-id-type="pmid">20089879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ratra</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dalan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jandyal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bhende</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jayaprakash</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Susvar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Walinjkar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Enhanced S-cone syndrome: Clinical spectrum in Indian population.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>523</fpage>
            <page-range>523-529</page-range>
            <pub-id pub-id-type="pmid">30900587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Basu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vohra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Triads in Ophthalmology: A Comprehensive Review.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2017</year>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>237</fpage>
            <page-range>237-250</page-range>
            <pub-id pub-id-type="pmid">26148300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hartong</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Berson</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Dryja</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Retinitis pigmentosa.</article-title>
            <source>Lancet</source>
            <year>2006</year>
            <month>Nov</month>
            <day>18</day>
            <volume>368</volume>
            <issue>9549</issue>
            <fpage>1795</fpage>
            <page-range>1795-809</page-range>
            <pub-id pub-id-type="pmid">17113430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heckenlively</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Fawzi</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Oversier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Aptsiauri</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>118</volume>
            <issue>11</issue>
            <fpage>1525</fpage>
            <page-range>1525-33</page-range>
            <pub-id pub-id-type="pmid">11074809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r114">
          <label>114</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nieuwendijk</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Hooymans</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic vitelliform retinopathy associated with metastatic choroidal melanoma.</article-title>
            <source>Eye (Lond)</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>21</volume>
            <issue>11</issue>
            <fpage>1436</fpage>
            <page-range>1436-7</page-range>
            <pub-id pub-id-type="pmid">17693995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r115">
          <label>115</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elsheikh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gurney</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Burdon</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Melanoma-associated retinopathy.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>147</fpage>
            <page-range>147-152</page-range>
            <pub-id pub-id-type="pmid">31742740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r116">
          <label>116</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jan&#x000e1;ky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>P&#x000e1;lffy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kolozsv&#x000e1;ri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Benedek</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Unilateral manifestation of melanoma-associated retinopathy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>120</volume>
            <issue>6</issue>
            <fpage>866</fpage>
            <page-range>866-7</page-range>
            <pub-id pub-id-type="pmid">12049605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r117">
          <label>117</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fujiwara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Imamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Giovinazzo</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Fundus autofluorescence and optical coherence tomographic findings in acute zonal occult outer retinopathy.</article-title>
            <source>Retina</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>8</issue>
            <fpage>1206</fpage>
            <page-range>1206-16</page-range>
            <pub-id pub-id-type="pmid">20661173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r118">
          <label>118</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Forooghian</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Faia</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Cukras</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lew</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Wroblewski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Weichel</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Meyerle</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Fundus autofluorescence imaging of the white dot syndromes.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>128</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-56</page-range>
            <pub-id pub-id-type="pmid">20065216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r119">
          <label>119</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamel</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Cone rod dystrophies.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2007</year>
            <month>Feb</month>
            <day>01</day>
            <volume>2</volume>
            <fpage>7</fpage>
            <pub-id pub-id-type="pmid">17270046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r120">
          <label>120</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iijima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kogure</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hosaka</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Shibutani</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Electroretinogram in cone dystrophy.</article-title>
            <source>Jpn J Ophthalmol</source>
            <year>1991</year>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>453</fpage>
            <page-range>453-66</page-range>
            <pub-id pub-id-type="pmid">1821435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r121">
          <label>121</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Toxic optic neuropathy.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2011</year>
            <season>Mar-Apr</season>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-41</page-range>
            <pub-id pub-id-type="pmid">21350283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r122">
          <label>122</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Margolin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Blair</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shemesh</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Toxic and Nutritional Optic Neuropathy</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>16</day>
            <pub-id pub-id-type="pmid">29763154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r123">
          <label>123</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sajjadi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Poorsalman</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Previously Diagnosed Leber's Hereditary Optic Neuropathy with Clinical Signs of Idiopathic Intracranial Hypertension Responsive to Acetazolamide Therapy.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2019</year>
            <season>Jan-Mar</season>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>109</fpage>
            <page-range>109-113</page-range>
            <pub-id pub-id-type="pmid">30820297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r124">
          <label>124</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mauri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dilena</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boccazzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ronchi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Piga</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Triulzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gagliardi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brusa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Faravelli</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bresolin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Magri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Corti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Comi</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Subclinical Leber's hereditary optic neuropathy with pediatric acute spinal cord onset: more than meets the eye.</article-title>
            <source>BMC Neurol</source>
            <year>2018</year>
            <month>Dec</month>
            <day>27</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>220</fpage>
            <pub-id pub-id-type="pmid">30591017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r125">
          <label>125</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glover</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Casmaer</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>April</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>An uncommon cause of vision loss: Leber hereditary optic neuropathy.</article-title>
            <source>JAAPA</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>31</volume>
            <issue>11</issue>
            <fpage>32</fpage>
            <page-range>32-34</page-range>
            <pub-id pub-id-type="pmid">30358677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r126">
          <label>126</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Savini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Barboni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Valentino</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Montagna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cortelli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Negri</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sadun</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bianchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Longanesi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zanini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carelli</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations.</article-title>
            <source>Ophthalmology</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>112</volume>
            <issue>1</issue>
            <fpage>127</fpage>
            <page-range>127-31</page-range>
            <pub-id pub-id-type="pmid">15629832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r127">
          <label>127</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quiros</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Salomao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Berezovsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carelli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sadun</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Negri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Belfort</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sadun</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Colour vision defects in asymptomatic carriers of the Leber's hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>90</volume>
            <issue>2</issue>
            <fpage>150</fpage>
            <page-range>150-3</page-range>
            <pub-id pub-id-type="pmid">16424523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r128">
          <label>128</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadun</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Salomao</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Berezovsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sadun</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Denegri</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Quiros</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Chicani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ventura</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Barboni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sutter</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Belfort</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Carelli</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>2006</year>
            <volume>104</volume>
            <fpage>51</fpage>
            <page-range>51-61</page-range>
            <pub-id pub-id-type="pmid">17471325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r129">
          <label>129</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu-Wai-Man</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Hudson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chinnery</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Inherited mitochondrial optic neuropathies.</article-title>
            <source>J Med Genet</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>145</fpage>
            <page-range>145-58</page-range>
            <pub-id pub-id-type="pmid">19001017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r130">
          <label>130</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riordan-Eva</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Harding</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Leber's hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations.</article-title>
            <source>J Med Genet</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>81</fpage>
            <page-range>81-7</page-range>
            <pub-id pub-id-type="pmid">7760326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r131">
          <label>131</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Machemer</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[On the pathogenesis of the flat malignant melanoma].</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>1966</year>
            <volume>148</volume>
            <issue>5</issue>
            <fpage>641</fpage>
            <page-range>641-52</page-range>
            <pub-id pub-id-type="pmid">5996537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r132">
          <label>132</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barr</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Curtin</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Font</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Bilateral diffuse melanocytic uveal tumors associated with systemic malignant neoplasms. A recently recognized syndrome.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1982</year>
            <month>Feb</month>
            <volume>100</volume>
            <issue>2</issue>
            <fpage>249</fpage>
            <page-range>249-55</page-range>
            <pub-id pub-id-type="pmid">7065942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r133">
          <label>133</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Noort</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Keunen</surname>
                <given-names>JEE</given-names>
              </name>
              <name>
                <surname>Schlingemann</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Marinkovic</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Long Survival and Preservation of Good Visual Acuity in a Patient with Bilateral Diffuse Uveal Melanocytic Proliferation.</article-title>
            <source>Ocul Oncol Pathol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-78</page-range>
            <pub-id pub-id-type="pmid">30675481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r134">
          <label>134</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klemp</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kiilgaard</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Heegaard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>N&#x000f8;rgaard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Prause</surname>
                <given-names>JU</given-names>
              </name>
            </person-group>
            <article-title>Bilateral diffuse uveal melanocytic proliferation: Case report and literature review.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>95</volume>
            <issue>5</issue>
            <fpage>439</fpage>
            <page-range>439-445</page-range>
            <pub-id pub-id-type="pmid">28636126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r135">
          <label>135</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Gieser</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Beahm</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Pautler</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1990</year>
            <month>Apr</month>
            <volume>108</volume>
            <issue>4</issue>
            <fpage>527</fpage>
            <page-range>527-33</page-range>
            <pub-id pub-id-type="pmid">2322154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r136">
          <label>136</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahimy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Soheilian</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Giraffe Pattern of Bilateral Diffuse Uveal Melanocytic Proliferation.</article-title>
            <source>Ophthalmology</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>123</volume>
            <issue>3</issue>
            <fpage>483</fpage>
            <pub-id pub-id-type="pmid">26902560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r137">
          <label>137</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chahud</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Remulla</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Khadem</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Dryja</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Bilateral diffuse uveal melanocytic proliferation associated with extraocular cancers: review of a process particularly associated with gynecologic cancers.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>212</fpage>
            <page-range>212-8</page-range>
            <pub-id pub-id-type="pmid">11176070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r138">
          <label>138</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY: A Systematic Review and Meta-Analysis.</article-title>
            <source>Retina</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-19</page-range>
            <pub-id pub-id-type="pmid">26710181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r139">
          <label>139</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000e4;ckle</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Freissler</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>[Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects].</article-title>
            <source>Ophthalmologe</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>95</volume>
            <issue>8</issue>
            <fpage>529</fpage>
            <page-range>529-33</page-range>
            <pub-id pub-id-type="pmid">9782727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r140">
          <label>140</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tittl</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pilotto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Systemic findings associated with central serous chorioretinopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>128</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-8</page-range>
            <pub-id pub-id-type="pmid">10482095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r141">
          <label>141</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yalcinbayir</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Gelisken</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Akova-Budak</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ozkaya</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gorkem Cevik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yucel</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy.</article-title>
            <source>Retina</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>705</fpage>
            <page-range>705-12</page-range>
            <pub-id pub-id-type="pmid">24100708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r142">
          <label>142</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Central Serous Chorioretinopathy</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32644399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r143">
          <label>143</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Distinct clinical characteristics of paraneoplastic optic neuropathy.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>103</volume>
            <issue>6</issue>
            <fpage>797</fpage>
            <page-range>797-801</page-range>
            <pub-id pub-id-type="pmid">30021813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r144">
          <label>144</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Furlan</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Sweeney</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Kosmorsky</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Optic neuropathy: a rare paraneoplastic syndrome.</article-title>
            <source>J Clin Neuroophthalmol</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>137</fpage>
            <page-range>137-41</page-range>
            <pub-id pub-id-type="pmid">1328306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r145">
          <label>145</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paul</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic optic neuritis as the first manifestation of periampullary carcinoma.</article-title>
            <source>Int J Appl Basic Med Res</source>
            <year>2015</year>
            <season>Jan-Apr</season>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-5</page-range>
            <pub-id pub-id-type="pmid">25664276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r146">
          <label>146</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosencher</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Maisonobe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lavole</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Milleron</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ferroir</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>[Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].</article-title>
            <source>Rev Neurol (Paris)</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>168</volume>
            <issue>4</issue>
            <fpage>371</fpage>
            <page-range>371-4</page-range>
            <pub-id pub-id-type="pmid">22387203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r147">
          <label>147</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Langer</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Fountain</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Pranzatelli</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Rust</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Goodkin</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>An unusual presentation of anti-Hu-associated paraneoplastic limbic encephalitis.</article-title>
            <source>Dev Med Child Neurol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>54</volume>
            <issue>9</issue>
            <fpage>863</fpage>
            <page-range>863-6</page-range>
            <pub-id pub-id-type="pmid">22320677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r148">
          <label>148</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Damek</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic Retinopathy/Optic Neuropathy.</article-title>
            <source>Curr Treat Options Neurol</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-67</page-range>
            <pub-id pub-id-type="pmid">15610708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r149">
          <label>149</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiseman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Bar-El Dadon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reifen</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The vicious cycle of vitamin a deficiency: A review.</article-title>
            <source>Crit Rev Food Sci Nutr</source>
            <year>2017</year>
            <month>Nov</month>
            <day>22</day>
            <volume>57</volume>
            <issue>17</issue>
            <fpage>3703</fpage>
            <page-range>3703-3714</page-range>
            <pub-id pub-id-type="pmid">27128154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r150">
          <label>150</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Ambrosio</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Clugston</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Blaner</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Vitamin A metabolism: an update.</article-title>
            <source>Nutrients</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-103</page-range>
            <pub-id pub-id-type="pmid">21350678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r151">
          <label>151</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Sternberg</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Schleicher</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Haynes</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Rybak</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Pirkle</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>The CDC's Second National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population is a valuable tool for researchers and policy makers.</article-title>
            <source>J Nutr</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>143</volume>
            <issue>6</issue>
            <fpage>938S</fpage>
            <page-range>938S-47S</page-range>
            <pub-id pub-id-type="pmid">23596164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r152">
          <label>152</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Hodge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <chapter-title>Vitamin A Deficiency</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>1</month>
            <day>2</day>
            <pub-id pub-id-type="pmid">33620821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r153">
          <label>153</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Humphrey</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marinda</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Brookmeyer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Why do children become vitamin A deficient?</article-title>
            <source>J Nutr</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>132</volume>
            <issue>9 Suppl</issue>
            <fpage>2867S</fpage>
            <page-range>2867S-2880S</page-range>
            <pub-id pub-id-type="pmid">12221263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r154">
          <label>154</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McBain</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Egan</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Pieris</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Supramaniam</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Webster</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Holder</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Functional observations in vitamin A deficiency: diagnosis and time course of recovery.</article-title>
            <source>Eye (Lond)</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>367</fpage>
            <page-range>367-76</page-range>
            <pub-id pub-id-type="pmid">16341129</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r155">
          <label>155</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aleman</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Garrity</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Brucker</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Retinal structure in vitamin A deficiency as explored with multimodal imaging.</article-title>
            <source>Doc Ophthalmol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>127</volume>
            <issue>3</issue>
            <fpage>239</fpage>
            <page-range>239-43</page-range>
            <pub-id pub-id-type="pmid">23900584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r156">
          <label>156</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilbert</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The eye signs of vitamin A deficiency.</article-title>
            <source>Community Eye Health</source>
            <year>2013</year>
            <volume>26</volume>
            <issue>84</issue>
            <fpage>66</fpage>
            <page-range>66-7</page-range>
            <pub-id pub-id-type="pmid">24782581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r157">
          <label>157</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldstein</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Syed</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Milam</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Maguire</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Lawton</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Nichols</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Cancer-associated retinopathy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>117</volume>
            <issue>12</issue>
            <fpage>1641</fpage>
            <page-range>1641-5</page-range>
            <pub-id pub-id-type="pmid">10604671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143074.r158">
          <label>158</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schiffman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Iannaccone</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy.</article-title>
            <source>J Ophthalmic Inflamm Infect</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>111</fpage>
            <page-range>111-21</page-range>
            <pub-id pub-id-type="pmid">21744285</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
